
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Synthesis, In Silico
Studies, and In Vitro Anti-Inflammatory
Activity of Novel Imidazole Derivatives Targeting p38 MAP Kinase - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F39205000024981008F397.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="acsomega" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10210024/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210024/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="ACS Omega" /><meta name="citation_title" content="Synthesis, In Silico&#10;Studies, and In Vitro Anti-Inflammatory&#10;Activity of Novel Imidazole Derivatives Targeting p38 MAP Kinase" /><meta name="citation_author" content="Archana Awasthi" /><meta name="citation_author_institution" content="Department of Pharmaceutical Chemistry, Sri Venkateshwara College of Pharmacy, Madhapur, Hyderabad 500081, Telangana, India" /><meta name="citation_author_institution" content="Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India" /><meta name="citation_author" content="Md Azizur Rahman" /><meta name="citation_author_institution" content="Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India" /><meta name="citation_author" content="Mantripragada Bhagavan Raju" /><meta name="citation_author_institution" content="Department of Pharmaceutical Chemistry, Sri Venkateshwara College of Pharmacy, Madhapur, Hyderabad 500081, Telangana, India" /><meta name="citation_publication_date" content="2023/05/05" /><meta name="citation_issue" content="20" /><meta name="citation_volume" content="8" /><meta name="citation_firstpage" content="17788" /><meta name="citation_doi" content="10.1021/acsomega.3c00605" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10210024/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10210024/" /><meta name="citation_pmid" content="37251188" /><meta name="DC.Title" content="Synthesis, In Silico&#10;Studies, and In Vitro Anti-Inflammatory&#10;Activity of Novel Imidazole Derivatives Targeting p38 MAP Kinase" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="American Chemical Society" /><meta name="DC.Contributor" content="Archana Awasthi" /><meta name="DC.Contributor" content="Md Azizur Rahman" /><meta name="DC.Contributor" content="Mantripragada Bhagavan Raju" /><meta name="DC.Date" content="2023 May 23" /><meta name="DC.Identifier" content="10.1021/acsomega.3c00605" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Synthesis, In Silico&#10;Studies, and In Vitro Anti-Inflammatory&#10;Activity of Novel Imidazole Derivatives Targeting p38 MAP Kinase" /><meta property="og:type" content="article" /><meta property="og:description" content="A series of eight novel N-substituted&#10;[4-(trifluoro&#10;methyl)-1H-imidazole-1-yl] amide derivatives (AA1&#x02013;AA8) were synthesized, characterized, and evaluated&#10;for their in vitro p38 MAP kinase anti-inflammatory inhibitory activity.&#10;The synthesized ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210024/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10210024/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3686/">ACS Omega</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/436550/">v.8(20); 2023 May 23</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10210024
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10210024/pdf/ao3c00605.pdf" class="int-view">PDF (4.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10210024/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10210024/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10210024" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10210024%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="1CLgcmIFptsTIqxRlbKRx0CHyjvXL4LDcCvo57wZLHyvUxFRJayHOCz1MaIGfkRo">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10210024%2F&amp;text=Synthesis%2C%20In%20Silico%0AStudies%2C%20and%20In%20Vitro%20Anti-Inflammatory%0AActivity%20of%20Novel%20Imidazole%20Derivatives%20Targeting%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10210024%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210024/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10210024/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37251188/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10210024/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37251188/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10210024/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10210024/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3686/">ACS Omega</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/436550/">v.8(20); 2023 May 23</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10210024
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-acsomega.png" alt="Logo of acsomega" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://pubs.acs.org/journal/acsodf" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">ACS Omega.</span> 2023 May 23; 8(20): 17788–17799. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 May 12. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1021%2Facsomega.3c00605" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1021/acsomega.3c00605</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10210024</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37251188">37251188</a></div></div></div><h1 class="content-title">Synthesis, In Silico
Studies, and In Vitro Anti-Inflammatory
Activity of Novel Imidazole Derivatives Targeting p38 MAP Kinase</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Awasthi%20A%5BAuthor%5D" id="ath1" class="affpopup" co-rid="_co_idm140272261774736" co-class="co-affbox">Archana Awasthi</a>,<sup>&#x02020;</sup><sup>&#x02021;</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Rahman%20MA%5BAuthor%5D" id="ath2" class="affpopup" co-rid="_co_idm140272261772720" co-class="co-affbox">Md Azizur Rahman</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><a href="#cor1" rid="cor1" class=" other">*</a><sup>&#x02021;</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bhagavan%20Raju%20M%5BAuthor%5D" id="ath3" class="affpopup" co-rid="_co_idm140272260751024" co-class="co-affbox">Mantripragada Bhagavan Raju</a><sup>&#x02020;</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140272261774736"><h3 class="no_margin">Archana Awasthi</h3><p><sup>&#x02020;</sup>Department
of Pharmaceutical Chemistry, Sri Venkateshwara
College of Pharmacy, Madhapur, Hyderabad 500081, Telangana, India</p><p><sup>&#x02021;</sup>Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Awasthi%20A%5BAuthor%5D">Archana Awasthi</a></div></div><div id="_co_idm140272261772720"><h3 class="no_margin">Md Azizur Rahman</h3><p><sup>&#x02021;</sup>Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Rahman%20MA%5BAuthor%5D">Md Azizur Rahman</a></div></div><div id="_co_idm140272260751024"><h3 class="no_margin">Mantripragada Bhagavan Raju</h3><p><sup>&#x02020;</sup>Department
of Pharmaceutical Chemistry, Sri Venkateshwara
College of Pharmacy, Madhapur, Hyderabad 500081, Telangana, India</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Bhagavan%20Raju%20M%5BAuthor%5D">Mantripragada Bhagavan Raju</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140272259710992_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140272259710992_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140272259710992_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140272259710992_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>&#x02020;</sup>Department
of Pharmaceutical Chemistry, Sri Venkateshwara
College of Pharmacy, Madhapur, Hyderabad 500081, Telangana, India</div><div class="fm-affl" id="aff2"><sup>&#x02021;</sup>Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="cor1"><sup>*</sup>Email: <a href="mailto:dev@null" data-email="ni.ca.lui@namharam" class="oemail">ni.ca.lui@namharam</a>.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140272259710992_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jan 30; Accepted 2023 Apr 26.</div></div><div class="permissions half_rhythm hide" id="idm140272259710992_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 The Authors. Published by American Chemical Society</div><div class="license half_rhythm">Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://creativecommons.org/licenses/by-nc-nd/4.0/</a>).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">ao3c00605_si_001.pdf</div><div><a href="/pmc/articles/PMC10210024/bin/ao3c00605_si_001.pdf" data-ga-action="click_feat_suppl">ao3c00605_si_001.pdf</a><span style="color:gray"> (2.6M)</span></div><div class="small guid">GUID: E4F9715A-1714-43C4-B665-A9B956A233CE</div></div></dd></dl></div><div id="abstract-a.z.b.n" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.z.b.ntitle">Abstract</h2><!--article-meta--><div><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272261537536"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0012.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0012.jpg" src="/pmc/articles/PMC10210024/bin/ao3c00605_0012.jpg" /></div><p></p><p class="p p-last">A series of eight novel <em>N</em>-substituted
[4-(trifluoro
methyl)-1<em>H</em>-imidazole-1-yl] amide derivatives (<strong>AA1&#x02013;AA8</strong>) were synthesized, characterized, and evaluated
for their in vitro p38 MAP kinase anti-inflammatory inhibitory activity.
The synthesized compounds were obtained by coupling [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl] acetic acid with 2-amino-<em>N</em>-(Substituted)-3-phenylpropanamide derivatives utilizing 1-[bis(dimethylamino)methylene]-1<em>H</em>-1,2,3-triazolo[4,5-<em>b</em>] pyridinium 3-oxide
hexafluorophosphate as a coupling agent. Various spectroscopic methods
established and confirmed their structures, specifically, <sup>1</sup>H NMR, <sup>13</sup>C NMR, Fourier transform infrared (FTIR), and
mass spectrometry. In order to emphasize the binding site of the p38
MAP kinase protein and newly synthesized compounds, molecular docking
studies were carried out. In the series, compound <strong>AA6</strong> had the highest docking score of 7.83 kcal/mol. The ADME studies
were performed using web software. Studies revealed that all the synthesized
compounds were orally active and showed good gastrointestinal absorption
within the acceptable range. Lipinski&#x02019;s &#x0201c;rule of five&#x0201d;
was used to determine drug-likeness. The synthesized compounds were
screened for their anti-inflammatory activity by performing an albumin
denaturation assay in which five compounds (<strong>AA2</strong>, <strong>AA3</strong>, <strong>AA4</strong>, <strong>AA5</strong>, and <strong>AA6</strong>) were found to exhibit substantial activity. Hence, these were further
selected and proceeded for the evaluation of p38 MAP kinase inhibitory
activity. The compound <strong>AA6</strong> possesses considerable p38
kinase inhibitory anti-inflammatory activity with an IC<sub>50</sub> value of 403.57 &#x000b1; 6.35 nM compared to the prototype drug adezmapimod
(SB203580) with an IC<sub>50</sub> value of 222.44 &#x000b1; 5.98 nM.
Some further structural modifications in compound <strong>AA6</strong> could contribute to the development of new p38 MAP kinase inhibitors
with an improved IC<sub>50</sub> value.</p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">1. Introduction</h2><p class="p p-first">Inflammation is a biological
immune response that can be triggered
by the host&#x02019;s response to a variety of factors such as pathogens,
an infection caused by trauma or biological response, damaged cells,
or toxic compounds, which can result in the production of reactive
oxygen and nitrogen species, cytokinin release, and ultimately tissue
damage. Chronic inflammation can develop from acute inflammation as
a result of ongoing injury or personal circumstances (e.g., diabetes,
obesity, use of corticosteroids, blood disorders, etc.). Inflammation
leads to a variety of unpleasant symptoms and various diseases such
as rheumatoid arthritis, inflammatory bowel disease, cardiovascular
events, neurodegenerative conditions, cancer, COVID-19, and others.<sup><a href="#ref1" rid="ref1" class=" bibr popnode">1</a>&#x02212;<a href="#ref7" rid="ref7" class=" bibr popnode">7</a></sup> Therefore, one of the main objectives in the field of drug discovery
nowadays is the development of novel safe molecules with anti-inflammatory
effects. Nonsteroidal anti-inflammatory drugs are commonly used as
a medication to treat pain and inflammation.<sup><a href="#ref8" rid="ref8" class=" bibr popnode">8</a></sup></p><p>In terms of anti-inflammatory activity, drugs designed and
developed
to treat inflammation will target to inhibit either the inflammatory
proteins (C-reactive protein, haptoglobin, alpha 1-acid glycoprotein,
etc.) or enzymes (COX-2, LOX, PDE4, etc.) or inflammatory pathways
(MAPK, NF-&#x0039a;b, and JAK-STAT).<sup><a href="#ref9" rid="ref9" class=" bibr popnode">9</a></sup></p><p>Mitogen-activated protein kinases (MAPKs) are serine and threonine
protein kinases that are found in eukaryotes and are involved in signal
transduction pathways that regulate cell proliferation, differentiation,
motility, and survival in mammals. The MAPK family includes three
major members extracellular signal-regulated kinase, p38 MAPK, and
c-Jun N-terminal kinase, which are involved in three different signaling
cascades. Among them, p38 MAPK is considered a key role player in
inflammation, a stress-induced kinase.<sup><a href="#ref10" rid="ref10" class=" bibr popnode">10</a></sup> p38 MAPK family consists of four different isoforms, namely, p38
&#x003b1;, p38 &#x003b2;, p38 &#x003b4;, and p38 &#x003b3;.<sup><a href="#ref11" rid="ref11" class=" bibr popnode">11</a></sup> All these forms are in different locations and show different
cellular expressions. p38 &#x003b1; isoform is considered to be present
in all cells and tissues. MAP kinases play a central role in regulating
the production of pro-inflammatory cytokines including TNF-&#x003b1;,
IL-1&#x003b2;, and IL-6. Various potent and selective p38 MAP kinase
inhibitors are currently in phase II clinical studies for rheumatoid
arthritis, psoriasis, inflammatory bowel diseases, neuropathic pain,
cancer, depression, and cardiovascular diseases.<sup><a href="#ref12" rid="ref12" class=" bibr popnode">12</a></sup></p><p>SB203580 (adezmapimod) is a tri-substituted imidazole-based
p38
MAP kinase inhibitor in the pyridinyl imidazole class that is widely
used in the literature as an ATP-competitive ref (<a href="#ref13" rid="ref13" class=" bibr popnode">13</a>)<span class="underline">.</span> Several other novel imidazole derivatives, such as phenoxy pyrimidine,
pyrazolo pyridines, benzimidazole, etc., have clinical significance
as well, but only a few members of the pyridinyl imidazole class have
progressed into clinical trials for the treatment of rheumatoid arthritis.
None of the p38 MAP kinase inhibitors has been approved for market
release. This could be due to a number of factors, including ineffectiveness,
adverse effects, poor kinetics, or unspecific toxicity.<sup><a href="#ref14" rid="ref14" class=" bibr popnode">14</a></sup> The reported imidazole-based p38 MAP kinase
inhibitors are shown in <a href="/pmc/articles/PMC10210024/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1</span></span><span>1</span></a></span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC10210024/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272264666448"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0002.jpg" src="/pmc/articles/PMC10210024/bin/ao3c00605_0002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140272264666448"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p>Imidazole-based p38 MAP kinase inhibitors.</p></div></div></div><p>The aim of this research is to synthesize novel
trifluoromethyl
derivatives of imidazole via amide coupling of <em>t</em>-butyloxycarbonyl
(Boc) protected phenylalanine with different amine derivatives. Amides
are a vital class of organic molecules that have a wide range of applications
as useful synthetic intermediates. They are formed by the direct condensation
of carboxylic acids and amines, usually using a stoichiometric activating
agent. Wide varieties of activators are used in medicinal chemistry
as amide coupling via acid chloride, acid anhydride, activated ester,
boron species, etc.<sup><a href="#ref15" rid="ref15" class=" bibr popnode">15</a></sup> Amide bonds are fundamental
in drug discovery because they are one of the basic linkages in all
living systems.</p><p>Other approaches to amidation are thermal amidation,
ester amidation,
catalytic amidation, carbonylation, oxidative amidation, etc. Coupling
reactions are performed either in solution or on a solid phase, depending
on the nature of the amine. The solvent used in an amide coupling
reaction is also very important. Dipolar aprotic solvents such as <em>N</em>-methyl-2-pyrrolidinone, <em>N</em>,<em>N</em>-dimethylformamide (DMF), CH<sub>2</sub>Cl<sub>2</sub>, and <em>N,N</em> dimethylacetamide are generally used.<sup><a href="#ref16" rid="ref16" class=" bibr popnode">16</a></sup></p><p>In this research, 2-[(<em>tert</em>-butoxycarbonyl)
amino]-3-phenylpropanoic
acid is coupled with various aromatic amine derivatives utilizing
1-[Bis(dimethylamino)methylene]-1<em>H</em>-1,2,3-triazolo[4,5-<em>b</em>] pyridinium 3-oxide hexafluorophosphate (HATU) as an activating/coupling
agent and DMF as a dipolar aprotic solvent.</p><p class="p p-last">HATU is used when
the coupling partners have a sensitive functional
group. It provides faster couplings with less epimerization. It is
also employed when the sterically hindered group is generally present.
Due to its mild reaction conditions and usually high yields of amide
product, this reagent has seen prevalent use as a coupling reagent
for amide bond formation.<sup><a href="#ref17" rid="ref17" class=" bibr popnode">17</a></sup></p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">2. Results and Discussion</h2><div id="sec2.1" class="sec sec-first"><h3 id="sec2.1title">2.1. Chemistry</h3><p class="p p-first">The synthesis of the <em>N</em>-substituted [4-(trifluoro methyl)-1<em>H</em>-imidazole-1-yl]
amide derivatives (<strong>AA1</strong> to <strong>AA8</strong>) is a three-step
reaction in which the second and third steps are based on coupling
reactions. The detail of the reaction scheme is described in <a href="/pmc/articles/PMC10210024/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2</span></span><span>2</span></a></span></a>. The structure of
the final compounds is shown in <a href="/pmc/articles/PMC10210024/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3</span></span><span>3</span></a></span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC10210024/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272265737184"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0003.jpg" src="/pmc/articles/PMC10210024/bin/ao3c00605_0003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140272265737184"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p>Reaction scheme showing the synthetic pathway of the <em>N</em>-substituted [4-(trifluoro methyl)-1<em>H</em>-imidazole-1-yl]
amide derivative (<strong>AA1</strong>&#x02013;<strong>AA8</strong>).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC10210024/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272265732592"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0004.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0004.jpg" src="/pmc/articles/PMC10210024/bin/ao3c00605_0004.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140272265732592"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p>Structure of final synthesized compounds <em>N</em>-substituted
[4-(trifluoro methyl)-1<em>H</em>-imidazole-1-yl] amide derivative
(<strong>AA1</strong>&#x02013;<strong>AA8</strong>).</p></div></div></div><p>In the first step, 4-(trifluoromethyl)-1<em>H</em>-imidazole
(<strong>1</strong>) was acetylated with ethyl bromoacetate (<strong>2</strong>) to afford the methyl [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl]
acetate (<strong>3</strong>) which on hydrolysis yield [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl] acetic acid (<strong>4</strong>).</p><p>In
the second step, commercially available (<em>t</em>-butoxycarbonyl)-<span class="small-caps">l</span>-phenylalanine (<strong>5</strong>) was treated with various amines
(<strong>A1</strong> to <strong>A8</strong>) under a well-established method
using HATU as the coupling agent in the presence of <em>N</em>,<em>N</em>-diisopropylethylamine (DIPEA) as a base to afford
the {2-[(<em>t</em>-butoxycarbonyl) amino]-<em>N</em>-(substituted)}-3-phenylpropanamide derivatives (<strong>KO-A1</strong> to <strong>KO-A8</strong>) which were subsequently deprotected to yield
2-amino-<em>N</em>-(substituted)-3-phenyl propanamide derivatives
(<strong>KO-A1-D</strong> to <strong>KO-A8-D</strong>).<sup><a href="#ref18" rid="ref18" class=" bibr popnode">18</a></sup></p><p>In step three, [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl]
acetic acid (<strong>4</strong>) from step 1 was coupled with KO-A1-D
to KO-A8-D from step 2 using HATU to get the title compounds <strong>AA1</strong>&#x02013;<strong>AA8</strong>. All the compounds were identified
by spectral data like <sup>I</sup>H-NMR, <sup>13</sup>C NMR, Fourier
transform infrared (FTIR), and mass spectrometry (MS).</p><p class="p">The position
of the proton (in the alphabet) is mentioned in <a href="/pmc/articles/PMC10210024/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure4</span></span><span>4</span></a></span></a>. There were two
singlet amide peaks (a and c) between 7.5 ppm and 10 ppm chemical
shift in <sup>1</sup>H NMR. The &#x02212;CH<sub>2</sub> protons (d)
attached to the imidazole ring exhibited a peak between 4.73 and 4.76
ppm. The two aliphatic hydrogens (g and h) of phenylalanine are in
a different environment and hence display two distinct peaks at the
range between 2.87&#x02013;2.96 and 3.05&#x02013;3.93 ppm, respectively.
The most crucial linkage that justifies the production of the final
compound is the aliphatic &#x02212;CH proton (b), which is linked by
two amide groups on both sides in the range of 4.48 and 4.90 ppm.
In compounds AA1 and AA7, the chemical shift value shifted toward
the downfield at 3.85 and 3.80 ppm, respectively, displaying a singlet
peak as three protons are attached to oxygen. <sup>13</sup>C NMR spectra
exhibited a peak between 54 and 56 ppm of chemical shift for all compounds
showing the presence of carbon which is linked by two amide groups
on both sides. Methylene carbon is linked to the benzene and imidazole
rings exhibiting a peak at 49 and 38 ppm, respectively. Carbon attached
to three fluorine groups exhibited a peak near 121 ppm for all the
compounds. In compounds, AA5 and AA8, two sharp peaks of DMF solvent
were observed in <sup>1</sup>H NMR (2.72 and 2.88 ppm) and <sup>13</sup>C NMR (36.25 and 31.23 ppm). The FTIR spectrum of &#x02212;NH stretching
of amide showings an absorption band between 3265 and 3291 cm<sup>&#x02013;1</sup> and carbonyl group stretching is assigned for a peak
between 1640 and 1651 cm<sup>&#x02013;1</sup>. All compounds (AA1&#x02013;AA8)
exhibited the corresponding M<sup>+1</sup> peaks conforming to respective
molecular formulas. All the spectral data results suggested AA1 to
AA8 was successfully synthesized. The <sup>1</sup>H NMR, <sup>13</sup>C NMR, FTIR, and MS spectra of final compounds (AA1&#x02013;AA8) and <sup>1</sup>H NMR spectra of all the intermediate compounds (KO-A1 to
KO-A8, KO-A1-D to KO-A8-D, code 3, and code 4) were recorded in DMSO-<em>d</em><sub>6</sub> and the peak assignment has been mentioned
in the Characterization section and Supporting Information file.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC10210024/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272266414352"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272266414352"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p>Position
of protons (a&#x02013;m).</p></div></div></div></div><div id="sec2.2" class="sec"><h3 id="sec2.2title">2.2. In Vitro Anti-Inflammatory Activity</h3><div id="sec2.2.1" class="sec sec-first"><p></p><h4 id="sec2.2.1title" class="inline">2.2.1.  Albumin Denaturation Inhibitory Activity </h4><p class="p p-first">Albumin denaturation inhibitory activity is one of the most commonly
used assays for the preliminary evaluation of the anti-inflammatory
activity of various compounds. The synthesized compounds AA1&#x02013;AA8
were screened for anti-inflammatory activity by the inhibition of
the albumin denaturation technique in four different concentrations
such as 50, 100, 200, and 300 &#x003bc;g/mL and showed anti-inflammatory
activity in a dose-depending manner as listed in <a href="#tbl1" rid="tbl1" class=" other">Table <a href="#tbl1" rid="tbl1" class=" other">1</a></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl1"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Albumin Denaturation Inhibitory Activity
of Test Samples</strong></div><div class="xtable"><table frame="hsides" rules="groups" border="0" class="rendered small default_table"><thead><tr><th style="border:none;" align="center" rowspan="1" colspan="1">&#x000a0;</th><th colspan="4" align="center" rowspan="1">% inhibition
of protein denaturation (mean&#x000a0;&#x000b1;&#x000a0;SD)<hr /></th></tr><tr><th style="border:none;" align="center" rowspan="1" colspan="1">compounds</th><th style="border:none;" align="center" rowspan="1" colspan="1">Conc @ 50 &#x003bc;g/mL</th><th style="border:none;" align="center" rowspan="1" colspan="1">Conc @ 100 &#x003bc;g/mL</th><th style="border:none;" align="center" rowspan="1" colspan="1">Conc @ 200 &#x003bc;g/mL</th><th style="border:none;" align="center" rowspan="1" colspan="1">Conc @ 300 &#x003bc;g/mL</th></tr></thead><tbody><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA1</td><td style="border:none;" align="center" rowspan="1" colspan="1">19.25&#x000a0;&#x000b1;&#x000a0;1.22</td><td style="border:none;" align="center" rowspan="1" colspan="1">22.12&#x000a0;&#x000b1;&#x000a0;1.88</td><td style="border:none;" align="center" rowspan="1" colspan="1">34.22&#x000a0;&#x000b1;&#x000a0;2.01</td><td style="border:none;" align="center" rowspan="1" colspan="1">49.13&#x000a0;&#x000b1;&#x000a0;3.25</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA2</td><td style="border:none;" align="center" rowspan="1" colspan="1">18.23&#x000a0;&#x000b1;&#x000a0;1.02</td><td style="border:none;" align="center" rowspan="1" colspan="1">25.12&#x000a0;&#x000b1;&#x000a0;1.86</td><td style="border:none;" align="center" rowspan="1" colspan="1">36.28&#x000a0;&#x000b1;&#x000a0;2.34</td><td style="border:none;" align="center" rowspan="1" colspan="1">51.42&#x000a0;&#x000b1;&#x000a0;3.45</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA3</td><td style="border:none;" align="center" rowspan="1" colspan="1">19.65&#x000a0;&#x000b1;&#x000a0;1.24</td><td style="border:none;" align="center" rowspan="1" colspan="1">31.24&#x000a0;&#x000b1;&#x000a0;2.01</td><td style="border:none;" align="center" rowspan="1" colspan="1">45.21&#x000a0;&#x000b1;&#x000a0;2.96</td><td style="border:none;" align="center" rowspan="1" colspan="1">63.29&#x000a0;&#x000b1;&#x000a0;3.25</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA4</td><td style="border:none;" align="center" rowspan="1" colspan="1">25.36&#x000a0;&#x000b1;&#x000a0;1.63</td><td style="border:none;" align="center" rowspan="1" colspan="1">41.27&#x000a0;&#x000b1;&#x000a0;2.34</td><td style="border:none;" align="center" rowspan="1" colspan="1">59.22&#x000a0;&#x000b1;&#x000a0;3.48</td><td style="border:none;" align="center" rowspan="1" colspan="1">71.35&#x000a0;&#x000b1;&#x000a0;3.95</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA5</td><td style="border:none;" align="center" rowspan="1" colspan="1">22.14&#x000a0;&#x000b1;&#x000a0;1.34</td><td style="border:none;" align="center" rowspan="1" colspan="1">37.49&#x000a0;&#x000b1;&#x000a0;2.65</td><td style="border:none;" align="center" rowspan="1" colspan="1">48.23&#x000a0;&#x000b1;&#x000a0;2.98</td><td style="border:none;" align="center" rowspan="1" colspan="1">57.32&#x000a0;&#x000b1;&#x000a0;3.46</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA6</td><td style="border:none;" align="center" rowspan="1" colspan="1">39.55&#x000a0;&#x000b1;&#x000a0;1.96</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.21&#x000a0;&#x000b1;&#x000a0;3.54</td><td style="border:none;" align="center" rowspan="1" colspan="1">87.69&#x000a0;&#x000b1;&#x000a0;4.08</td><td style="border:none;" align="center" rowspan="1" colspan="1">93.26&#x000a0;&#x000b1;&#x000a0;4.66</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA7</td><td style="border:none;" align="center" rowspan="1" colspan="1">21.25&#x000a0;&#x000b1;&#x000a0;1.25</td><td style="border:none;" align="center" rowspan="1" colspan="1">23.12 &#x000b1; 1.76</td><td style="border:none;" align="center" rowspan="1" colspan="1">32.22 &#x000b1; 2.11</td><td style="border:none;" align="center" rowspan="1" colspan="1">50.13 &#x000b1; 3.37</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA8</td><td style="border:none;" align="center" rowspan="1" colspan="1">20.23&#x000a0;&#x000b1;&#x000a0;1.11</td><td style="border:none;" align="center" rowspan="1" colspan="1">22.12&#x000a0;&#x000b1;&#x000a0;1.72</td><td style="border:none;" align="center" rowspan="1" colspan="1">38.28&#x000a0;&#x000b1;&#x000a0;2.21</td><td style="border:none;" align="center" rowspan="1" colspan="1">51.63 &#x000b1; 3.22</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">diclofenac</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x000a0;</td><td style="border:none;" align="center" rowspan="1" colspan="1">82.53&#x000a0;&#x000b1;&#x000a0;3.25</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x000a0;</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">control</td><td colspan="4" align="center" rowspan="1">8.47&#x000a0;&#x000b1;&#x000a0;0.04</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">negative control (DMSO @ 0.1%)</td><td colspan="4" align="center" rowspan="1">8.69&#x000a0;&#x000b1;&#x000a0;0.03</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140272262632512"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/table/tbl1/?report=objectonly">Open in a separate window</a></div></div><p class="p">The IC<sub>50</sub> values are shown in <a href="/pmc/articles/PMC10210024/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure5</span></span><span>5</span></a></span></a>. The synthesized compounds
have IC<sub>50</sub> values in the &#x003bc;g/mL range, varying from
33.27 &#x000b1; 2.12
to 301.12 &#x000b1; 10.23 &#x003bc;g/mL compared to that of standard diclofenac
(IC<sub>50</sub> = 24.72 &#x000b1; 1.96 &#x003bc;g/mL).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig5" co-legend-rid="lgnd_fig5"><a href="/pmc/articles/PMC10210024/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272259944784"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272259944784"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig5"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p>IC<sub>50</sub> of Albumin
denaturation inhibitory activity in
&#x003bc;g/mL.</p></div></div></div></div><div id="sec2.2.2" class="sec sec-last"><p></p><h4 id="sec2.2.2title" class="inline">2.2.2.  p38 MAP Kinase Anti-Inflammatory Inhibitory
Activity </h4><p class="p p-first">Among the synthesized derivatives, five compounds
(AA2, AA3, AA4, AA5, and AA6) were found to exhibit substantial activity
in the protein denaturation assay; hence, these compounds were further
selected and proceeded for p38 MAP kinase inhibitory activity.</p><p class="p">The p38 MAP kinase inhibitory activity of selected compounds is described
in <a href="#tbl2" rid="tbl2" class=" other">Table <a href="#tbl2" rid="tbl2" class=" other">2</a></a> and <a href="/pmc/articles/PMC10210024/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure6</span></span><span>6</span></a></span></a>. The effectiveness
of the p38 kinase inhibitory activity was estimated with serial dilutions
ranging from 10 to 1000 nM. It was observed that the p38 kinase inhibitory
activity increases with the increase in concentration for all selected
compounds. IC<sub>50</sub> values of the p38 kinase enzyme inhibition
are summarized in <a href="/pmc/articles/PMC10210024/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure7</span></span><span>7</span></a></span></a>. It has been observed that the compound contains dimethyl
substitution at the second and fourth positions as AA6 (IC<sub>50</sub> value of 403.57 &#x000b1; 6.35 nM) exhibits considerable activity compared
to the prototype drug adezmapimod (IC<sub>50</sub> value 222.44 &#x000b1;
5.98 nM), which infers that AA6 can contribute toward p38 MAP kinase
activity.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig6" co-legend-rid="lgnd_fig6"><a href="/pmc/articles/PMC10210024/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272268134736"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0007.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0007.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272268134736"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig6"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p>p38 MAP kinase activity (in percent, %) of selected compounds.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig7" co-legend-rid="lgnd_fig7"><a href="/pmc/articles/PMC10210024/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272268131776"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0008.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0008.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0008.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272268131776"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig7"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7">Figure 7</a></div><!--caption a7--><div class="caption"><p>IC<sub>50</sub> of selected compounds as a function of
p38 kinase
inhibitory activity.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl2"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Effect of Selected Compounds on p38
MAP Kinase Activity</strong></div><div class="xtable"><table frame="hsides" rules="groups" border="0" class="rendered small default_table"><thead><tr><th style="border:none;" align="center" rowspan="1" colspan="1">&#x000a0;</th><th colspan="6" align="center" rowspan="1">p38
MAP kinase activity (in %) (mean&#x000a0;&#x000b1;&#x000a0;SD)<hr /></th></tr><tr><th style="border:none;" align="center" rowspan="1" colspan="1">concentration
(nM)</th><th style="border:none;" align="center" rowspan="1" colspan="1">AA2</th><th style="border:none;" align="center" rowspan="1" colspan="1">AA3</th><th style="border:none;" align="center" rowspan="1" colspan="1">AA4</th><th style="border:none;" align="center" rowspan="1" colspan="1">AA5</th><th style="border:none;" align="center" rowspan="1" colspan="1">AA6</th><th style="border:none;" align="center" rowspan="1" colspan="1">adezmapimod (SB203580)</th></tr></thead><tbody><tr><td style="border:none;" align="left" rowspan="1" colspan="1">10</td><td style="border:none;" align="left" rowspan="1" colspan="1">99.23&#x000a0;&#x000b1;&#x000a0;3.25</td><td style="border:none;" align="left" rowspan="1" colspan="1">99.21&#x000a0;&#x000b1;&#x000a0;4.17</td><td style="border:none;" align="left" rowspan="1" colspan="1">98.32&#x000a0;&#x000b1;&#x000a0;3.12</td><td style="border:none;" align="left" rowspan="1" colspan="1">98.15&#x000a0;&#x000b1;&#x000a0;3.14</td><td style="border:none;" align="left" rowspan="1" colspan="1">95.07&#x000a0;&#x000b1;&#x000a0;3.48</td><td style="border:none;" align="left" rowspan="1" colspan="1">92.36&#x000a0;&#x000b1;&#x000a0;4.15</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">25</td><td style="border:none;" align="left" rowspan="1" colspan="1">97.24&#x000a0;&#x000b1;&#x000a0;2.96</td><td style="border:none;" align="left" rowspan="1" colspan="1">98.04&#x000a0;&#x000b1;&#x000a0;2.56</td><td style="border:none;" align="left" rowspan="1" colspan="1">96.33&#x000a0;&#x000b1;&#x000a0;2.96</td><td style="border:none;" align="left" rowspan="1" colspan="1">96.02&#x000a0;&#x000b1;&#x000a0;2.86</td><td style="border:none;" align="left" rowspan="1" colspan="1">92.18&#x000a0;&#x000b1;&#x000a0;4.26</td><td style="border:none;" align="left" rowspan="1" colspan="1">84.11&#x000a0;&#x000b1;&#x000a0;3.25</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">50</td><td style="border:none;" align="left" rowspan="1" colspan="1">94.15&#x000a0;&#x000b1;&#x000a0;3.18</td><td style="border:none;" align="left" rowspan="1" colspan="1">96.35&#x000a0;&#x000b1;&#x000a0;2.94</td><td style="border:none;" align="left" rowspan="1" colspan="1">92.14&#x000a0;&#x000b1;&#x000a0;4.15</td><td style="border:none;" align="left" rowspan="1" colspan="1">92.14&#x000a0;&#x000b1;&#x000a0;3.42</td><td style="border:none;" align="left" rowspan="1" colspan="1">83.52&#x000a0;&#x000b1;&#x000a0;2.36</td><td style="border:none;" align="left" rowspan="1" colspan="1">64.56&#x000a0;&#x000b1;&#x000a0;2.96</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">100</td><td style="border:none;" align="left" rowspan="1" colspan="1">89.21&#x000a0;&#x000b1;&#x000a0;4.12</td><td style="border:none;" align="left" rowspan="1" colspan="1">92.34&#x000a0;&#x000b1;&#x000a0;3.21</td><td style="border:none;" align="left" rowspan="1" colspan="1">89.93&#x000a0;&#x000b1;&#x000a0;3.08</td><td style="border:none;" align="left" rowspan="1" colspan="1">87.34&#x000a0;&#x000b1;&#x000a0;3.55</td><td style="border:none;" align="left" rowspan="1" colspan="1">64.01&#x000a0;&#x000b1;&#x000a0;3.24</td><td style="border:none;" align="left" rowspan="1" colspan="1">41.36&#x000a0;&#x000b1;&#x000a0;3.48</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">250</td><td style="border:none;" align="left" rowspan="1" colspan="1">80.45&#x000a0;&#x000b1;&#x000a0;3.24</td><td style="border:none;" align="left" rowspan="1" colspan="1">85.38&#x000a0;&#x000b1;&#x000a0;3.48</td><td style="border:none;" align="left" rowspan="1" colspan="1">76.21&#x000a0;&#x000b1;&#x000a0;2.96</td><td style="border:none;" align="left" rowspan="1" colspan="1">83.04&#x000a0;&#x000b1;&#x000a0;3.75</td><td style="border:none;" align="left" rowspan="1" colspan="1">44.35&#x000a0;&#x000b1;&#x000a0;3.75</td><td style="border:none;" align="left" rowspan="1" colspan="1">22.01&#x000a0;&#x000b1;&#x000a0;4.25</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">500</td><td style="border:none;" align="left" rowspan="1" colspan="1">73.12&#x000a0;&#x000b1;&#x000a0;2.18</td><td style="border:none;" align="left" rowspan="1" colspan="1">82.04&#x000a0;&#x000b1;&#x000a0;3.12</td><td style="border:none;" align="left" rowspan="1" colspan="1">63.01&#x000a0;&#x000b1;&#x000a0;3.23</td><td style="border:none;" align="left" rowspan="1" colspan="1">77.34&#x000a0;&#x000b1;&#x000a0;3.28</td><td style="border:none;" align="left" rowspan="1" colspan="1">29.75&#x000a0;&#x000b1;&#x000a0;4.12</td><td style="border:none;" align="left" rowspan="1" colspan="1">12.03&#x000a0;&#x000b1;&#x000a0;3.75</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">750</td><td style="border:none;" align="left" rowspan="1" colspan="1">66.35&#x000a0;&#x000b1;&#x000a0;3.12</td><td style="border:none;" align="left" rowspan="1" colspan="1">79.36&#x000a0;&#x000b1;&#x000a0;2.01</td><td style="border:none;" align="left" rowspan="1" colspan="1">53.17&#x000a0;&#x000b1;&#x000a0;3.12</td><td style="border:none;" align="left" rowspan="1" colspan="1">71.06&#x000a0;&#x000b1;&#x000a0;4.21</td><td style="border:none;" align="left" rowspan="1" colspan="1">19.52&#x000a0;&#x000b1;&#x000a0;2.36</td><td style="border:none;" align="left" rowspan="1" colspan="1">7.12&#x000a0;&#x000b1;&#x000a0;2.96</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">1000</td><td style="border:none;" align="left" rowspan="1" colspan="1">63.45&#x000a0;&#x000b1;&#x000a0;3.32</td><td style="border:none;" align="left" rowspan="1" colspan="1">74.12&#x000a0;&#x000b1;&#x000a0;4.74</td><td style="border:none;" align="left" rowspan="1" colspan="1">49.57&#x000a0;&#x000b1;&#x000a0;4.01</td><td style="border:none;" align="left" rowspan="1" colspan="1">63.25&#x000a0;&#x000b1;&#x000a0;4.13</td><td style="border:none;" align="left" rowspan="1" colspan="1">15.23&#x000a0;&#x000b1;&#x000a0;3.24</td><td style="border:none;" align="left" rowspan="1" colspan="1">4.69&#x000a0;&#x000b1;&#x000a0;3.77</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140272303456736"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/table/tbl2/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="sec2.3" class="sec"><h3 id="sec2.3title">2.3. Docking Analysis of p38 MAP Kinase Inhibitors</h3><p class="p p-first">The docking study was performed to investigate the binding affinity
of the novel <em>N</em>-substituted [4-(trifluoro methyl)-1<em>H</em>-imidazole-1-yl] amide derivative to the binding site of
the p38 &#x003b1; MAP kinase protein. The docking scores of eight newly
synthesized compounds (AA1 to AA8) and prototype drug SB203580 are
shown in <a href="#tbl3" rid="tbl3" class=" other">Table <a href="#tbl3" rid="tbl3" class=" other">3</a></a>. Here,
we describe the docking analysis of the three most potent compounds
(AA4, AA6, and AA8) based on the docking score. All three potent compounds
were found to include one or two methyl groups in their structures.
AA6 showed the highest dock score of &#x02212;7.83 kcal/mol followed
by AA4 and AA8 with dock scores of &#x02212;7.60 and &#x02212;7.55 kcal/mol,
respectively (AA6 &#x0003e; AA4 &#x0003e; AA8). Among them, the compounds with
two
methyl groups in their structures (AA6 and AA4) showed more binding
interaction with receptors in comparison to compounds with one methyl
group (AA8). All the molecules displayed similar molecular interactions
with the active site of p38 MAP kinase and showed hydrogen bond interaction
with amino acid residue Asp 168, Lys 53, and Tyr 35.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl3"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Docking Score of Synthesized Compounds
and Adezmapimod</strong></div><div class="xtable"><table frame="hsides" rules="groups" border="0" class="rendered small default_table"><thead><tr><th style="border:none;" align="center" rowspan="1" colspan="1">molecules</th><th style="border:none;" align="center" rowspan="1" colspan="1">dock score (kcal/mol)</th><th style="border:none;" align="center" rowspan="1" colspan="1">amino acid
is involved in the interaction</th></tr></thead><tbody><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA1</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;6.89</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168, Lys 53, Ser
154, and Phe 169</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA2</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;7.26</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168, Lys 53, and Met109</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA3</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;7.46</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168 and Lys 53</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA4</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;7.60</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168, Lys 53,
and Tyr 35</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA5</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;6.44</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168, Lys 53, and Tyr 35</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA6</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;7.83</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168, Lys 53, Tyr 35, Arg 67,
and Arg 173</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA7</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;7.47</td><td style="border:none;" align="left" rowspan="1" colspan="1">Lys 53, Phe 169, Arg 67, Met109, and Glu 71</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA8</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;7.55</td><td style="border:none;" align="left" rowspan="1" colspan="1">Asp 168, Lys 53,
and Tyr 35</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">adezmapimod (SB203580)</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;8.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">Lys53, Met109, Ser 154, Glu 71,
Tyr 35, Val 38, and Ala 51</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140272306648016"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/table/tbl3/?report=objectonly">Open in a separate window</a></div></div><p class="p">Hydrophobic interaction in form of the &#x003c0;-anion
was observed
between molecules and amino residues Glu 71. Amino acid residues Val
38, Val 39, Leu 74, Leu 75, Ile 84, and Ala 172 showed an hydrophobic
interaction with docked molecules. <a href="/pmc/articles/PMC10210024/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure8</span></span><span>8</span></a></span></a> depicts dock positions and molecular interactions
of SB203580, while <a href="/pmc/articles/PMC10210024/figure/fig9/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig9" rid-ob="ob-fig9" co-legend-rid="lgnd_fig9"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig9/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig9" rid-ob="ob-fig9" co-legend-rid="lgnd_fig9"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure9</span></span><span>9</span></a></span></a> depicts that of the three most effective molecules AA8, AA6,
and AA4 (AA6 &#x0003e; AA4 &#x0003e; AA8).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig8" co-legend-rid="lgnd_fig8"><a href="/pmc/articles/PMC10210024/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272259822880"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0009.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0009.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0009.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272259822880"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig8"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8">Figure 8</a></div><!--caption a7--><div class="caption"><p>Docking pose and molecular interactions
of SB203580 in the active
site of p38 MAP kinase.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig9" co-legend-rid="lgnd_fig9"><a href="/pmc/articles/PMC10210024/figure/fig9/" target="figure" rid-figpopup="fig9" rid-ob="ob-fig9"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272261204192"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0010.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0010.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0010.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272261204192"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig9/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig9"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig9/" target="figure" rid-figpopup="fig9" rid-ob="ob-fig9">Figure 9</a></div><!--caption a7--><div class="caption"><p>(a,c,e) Docking poses of the compounds <strong>AA8</strong>, <strong>AA6</strong>, and <strong>AA4</strong> in the active site of p38
MAP kinase
and (b,d,f) are the molecular interactions of the compounds AA8, AA6,
and AA4 in the active site of p38 MAP kinase.</p></div></div></div></div><div id="sec2.4" class="sec sec-last"><h3 id="sec2.4title">2.4. ADME Studies</h3><p class="p p-first">Numerous techniques
have been developed to quantify the drug-likeness of bioactive compounds
based on topological descriptors of molecular structure or other features
such as molecular weight, water solubility, cLogP, etc. <a href="#tbl4" rid="tbl4" class=" other">Table <a href="#tbl4" rid="tbl4" class=" other">4</a></a> enlists the molecular characteristics
of compounds (AA1&#x02013;AA8). In this study, it was found that all
the synthesized compounds (AA1&#x02013;AA8) were orally active drugs
based on Lipinski&#x02019;s rule of five, polar surface area (&#x0003c;140
&#x000c5;<sup>2</sup>), rotatable bonds (&#x0003c;10), lipophilicity (recommended
range of &#x02212;2.0 to 6.5), and the BOILED-egg or Ergan&#x02019;s
egg approach. The graph indicated that all the compounds showed good
gastrointestinal absorption (GIA) within the acceptable range (WLOGP
&#x02264; 5.88 and TPSA &#x02264; 131.6), while one compound, AA6, is
absorbed by the brain also. The blue dot indicates molecules predicted
to be effluated from CNS by <em>p</em>-glycoprotein as in <a href="#tbl5" rid="tbl5" class=" other">Table <a href="#tbl5" rid="tbl5" class=" other">5</a></a> and <a href="/pmc/articles/PMC10210024/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure10</span></span><span>10</span></a></span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig10" co-legend-rid="lgnd_fig10"><a href="/pmc/articles/PMC10210024/figure/fig10/" target="figure" rid-figpopup="fig10" rid-ob="ob-fig10"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140272269400640"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10210024_ao3c00605_0011.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is ao3c00605_0011.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10210024/bin/ao3c00605_0011.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140272269400640"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/figure/fig10/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig10"><div><a class="figpopup" href="/pmc/articles/PMC10210024/figure/fig10/" target="figure" rid-figpopup="fig10" rid-ob="ob-fig10">Figure 10</a></div><!--caption a7--><div class="caption"><p>BOILED-Egg approach
to predict gastrointestinal absorption and
brain penetration of <em>N</em>-substituted [4-(trifluoro
methyl)-1<em>H</em>-imidazole-1-yl] amide derivatives.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl4"><h3>Table 4</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Physicochemical Properties of <em>N</em>-Substituted [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl]
Amide Derivatives<sup>a</sup></strong></div><div class="xtable"><table frame="hsides" rules="groups" border="0" class="rendered small default_table"><thead><tr><th style="border:none;" align="center" rowspan="1" colspan="1">compound</th><th style="border:none;" align="center" rowspan="1" colspan="1">MW</th><th style="border:none;" align="center" rowspan="1" colspan="1">Lipinski</th><th style="border:none;" align="center" rowspan="1" colspan="1">log <em>P</em></th><th style="border:none;" align="center" rowspan="1" colspan="1">log <em>S</em></th><th style="border:none;" align="center" rowspan="1" colspan="1">HBA</th><th style="border:none;" align="center" rowspan="1" colspan="1">HBD</th><th style="border:none;" align="center" rowspan="1" colspan="1">RB</th><th style="border:none;" align="center" rowspan="1" colspan="1">MR</th><th style="border:none;" align="center" rowspan="1" colspan="1">fraction
Csp3</th></tr></thead><tbody><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA1</td><td style="border:none;" align="center" rowspan="1" colspan="1">489.45</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">2.23</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;4.45</td><td style="border:none;" align="center" rowspan="1" colspan="1">8</td><td style="border:none;" align="center" rowspan="1" colspan="1">3</td><td style="border:none;" align="center" rowspan="1" colspan="1">12</td><td style="border:none;" align="center" rowspan="1" colspan="1">118.82</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.22</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA2</td><td style="border:none;" align="center" rowspan="1" colspan="1">448.41</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.71</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;5.03</td><td style="border:none;" align="center" rowspan="1" colspan="1">7</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">10</td><td style="border:none;" align="center" rowspan="1" colspan="1">109.16</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA3</td><td style="border:none;" align="center" rowspan="1" colspan="1">444.45</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.65</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;5.37</td><td style="border:none;" align="center" rowspan="1" colspan="1">6</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">11</td><td style="border:none;" align="center" rowspan="1" colspan="1">114.01</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA4</td><td style="border:none;" align="center" rowspan="1" colspan="1">444.45</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.67</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;5.3</td><td style="border:none;" align="center" rowspan="1" colspan="1">6</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">10</td><td style="border:none;" align="center" rowspan="1" colspan="1">114.17</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA5</td><td style="border:none;" align="center" rowspan="1" colspan="1">408.42</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">2.9</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;4.24</td><td style="border:none;" align="center" rowspan="1" colspan="1">6</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">10</td><td style="border:none;" align="center" rowspan="1" colspan="1">100.13</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA6</td><td style="border:none;" align="center" rowspan="1" colspan="1">444.45</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.69</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;5.3</td><td style="border:none;" align="center" rowspan="1" colspan="1">6</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">10</td><td style="border:none;" align="center" rowspan="1" colspan="1">114.17</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA7</td><td style="border:none;" align="center" rowspan="1" colspan="1">446.42</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.04</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;4.7</td><td style="border:none;" align="center" rowspan="1" colspan="1">7</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">11</td><td style="border:none;" align="center" rowspan="1" colspan="1">110.73</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA18</td><td style="border:none;" align="center" rowspan="1" colspan="1">430.42</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.43</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;4.92</td><td style="border:none;" align="center" rowspan="1" colspan="1">6</td><td style="border:none;" align="center" rowspan="1" colspan="1">2</td><td style="border:none;" align="center" rowspan="1" colspan="1">10</td><td style="border:none;" align="center" rowspan="1" colspan="1">109.2</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">SB203580</td><td style="border:none;" align="center" rowspan="1" colspan="1">377.43</td><td style="border:none;" align="center" rowspan="1" colspan="1">0</td><td style="border:none;" align="center" rowspan="1" colspan="1">3.87</td><td style="border:none;" align="center" rowspan="1" colspan="1">&#x02013;4.51</td><td style="border:none;" align="center" rowspan="1" colspan="1">4</td><td style="border:none;" align="center" rowspan="1" colspan="1">1</td><td style="border:none;" align="center" rowspan="1" colspan="1">4</td><td style="border:none;" align="center" rowspan="1" colspan="1">105.06</td><td style="border:none;" align="center" rowspan="1" colspan="1">0.05</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140272269395568"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/table/tbl4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t4fn1"><sup>a</sup>MW: molecular weight, log <em>P</em>: lipophilicity, log <em>S</em>: solubility, HBA:
number of hydrogen bond acceptors, HBD: number of hydrogen bond donors,
RB: rotatable bonds, and MR: molar refractivity.</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="tbl5"><h3>Table 5</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Pharmacokinetic Properties of <em>N</em>-Substituted [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl]
Amide Derivatives<sup>a</sup></strong></div><div class="xtable"><table frame="hsides" rules="groups" border="0" class="rendered small default_table"><thead><tr><th style="border:none;" align="center" rowspan="1" colspan="1">compound</th><th style="border:none;" align="center" rowspan="1" colspan="1">TPSA</th><th style="border:none;" align="center" rowspan="1" colspan="1">GIA</th><th style="border:none;" align="center" rowspan="1" colspan="1">BBB P</th><th style="border:none;" align="center" rowspan="1" colspan="1">Pgp S</th></tr></thead><tbody><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA1</td><td style="border:none;" align="center" rowspan="1" colspan="1">128.34</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">yes</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA2</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA3</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA4</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA5</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">yes</td><td style="border:none;" align="left" rowspan="1" colspan="1">yes</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA6</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA7</td><td style="border:none;" align="center" rowspan="1" colspan="1">85.25</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">AA8</td><td style="border:none;" align="center" rowspan="1" colspan="1">76.02</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td></tr><tr><td style="border:none;" align="left" rowspan="1" colspan="1">SB203580</td><td style="border:none;" align="center" rowspan="1" colspan="1">77.85</td><td style="border:none;" align="left" rowspan="1" colspan="1">high</td><td style="border:none;" align="left" rowspan="1" colspan="1">no</td><td style="border:none;" align="left" rowspan="1" colspan="1">yes</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140272260083088"><a target="object" rel="noopener" href="/pmc/articles/PMC10210024/table/tbl5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t5fn1"><sup>a</sup>TPSA: topological polar surface
area, GIA: gastrointestinal absorption, BBB P: blood brain barrier
permeation, and Pgp S: Pgp substrate.</div></div></div></div></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">3. Conclusions</h2><p class="p p-first">In summary, various <em>N</em>-substituted [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl]
amide derivatives were synthesized to
develop improved p38&#x003b1; MAP kinase inhibitors having significant
anti-inflammatory activity. The compound AA6 emerged as the most potent
compound in the series and shows considerable p38&#x003b1; MAP kinase
inhibitory activity. Furthermore, the molecular docking study of compound
AA6 demonstrated favorable orientation within the active binding site
of p38&#x003b1; MAP kinase with the docking score comparable to that
of the prototype p38&#x003b1; MAP kinase inhibitor SB203580. Based on
Lipinski&#x02019;s rule of five and Ergan&#x02019;s egg graph, ADME
experiments showed that all synthesized compounds were orally active
drugs. The compounds also demonstrated good gastrointestinal absorption
within the permissible range.</p><p class="p p-last">Our study concludes that compound
AA6 can be a promising compound
if further scaffolds with different substitutions are synthesized
for the development of more potent p38&#x003b1; MAP kinase inhibitors.</p></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">4. Experimental Section</h2><div id="sec4.1" class="sec sec-first"><h3 id="sec4.1title">4.1. Materials and Methods</h3><p class="p p-first-last">All the chemicals
used in the synthesis were supplied by E. Merck, Sigma-Aldrich, Avra,
and SD Fine Chemicals. <sup>1</sup>H NMR and <sup>13</sup>C NMR analyses
were carried out on a Bruker Avance 500 spectrometer using tetramethylsilane
as an internal standard and DMSO-<em>d</em><sub>6</sub> as
a solvent. Infrared spectra were recorded on a Perkin Elmer FTIR spectrophotometer
using KBr and mass spectra were obtained on an Agilant UHD-6450 mass
spectrometer. Melting points were recorded in open glass capillaries
and are uncorrected. Thin-layer chromatography was performed on pre-coated
silica gel plates and column chromatography was performed using silica
gel 60&#x02013;120 mesh.</p></div><div id="sec4.2" class="sec"><h3 id="sec4.2title">4.2. Synthetic Procedure</h3><p class="p p-first">The synthetic
route of target compounds (AA1&#x02013;AA8) is outlined in <a href="/pmc/articles/PMC10210024/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure <a href="/pmc/articles/PMC10210024/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure2</span></span><span>2</span></a></span></a>.</p><div id="sec4.2.1" class="sec"><p></p><h4 id="sec4.2.1title" class="inline">4.2.1.  Synthesis of [4-(Trifluoromethyl)-1<em>H</em>-imidazole-1-yl] Acetic Acid (<strong>4</strong>) </h4><p class="p p-first-last">A solution of the 4-(trifluoromethyl)-1<em>H</em>-imidazole
(<strong>1</strong>) (0.07 mol, 9.52 g) was mixed in DMF and treated with
K<sub>2</sub>CO<sub>3</sub> (0.14 mol, 19.55 g) and ethyl bromoacetate
(<strong>2</strong>) (0.07 mol, 13.01 g). The reaction mixture was stirred
for 18 h at 100 &#x000b0;C and ceased by adding a saturated NH<sub>4</sub>Cl (20 mL). The reaction mixture was extracted thrice with 150 mL
of ethyl acetate. The organic extracts were combined, dried over anhydrous
Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced
pressure to form crude methyl [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl] acetate (<strong>3</strong>) which was purified by column
chromatography with the yield of 85%. Crude product <strong>3</strong> was dissolved in methanol (1.0 mL) and water (0.3 mL) at room temperature
and then sodium hydroxide (0.01 mole, 3.87 g) was added. The stirring
was done overnight at room temperature. The pH was adjusted between
5 and 6 by the addition of aqueous HCl and the solution was concentrated
to half. Solid observed were filtered to yield 80% of [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl] acetic acid.</p></div><div id="sec4.2.2" class="sec"><p></p><h4 id="sec4.2.2title" class="inline">4.2.2.  General Procedure for the Synthesis of 2-Amino-<em>N</em>-(substituted)-3-phenylpropanamide Derivatives (<strong>KO-A1-D
to KO-A8-D</strong>) </h4><p class="p p-first">To a solution of commercially available
2-[(<em>tert</em>-butoxycarbonyl) amino]-3-phenylpropanoic
acid (<strong>5</strong>) (0.011 mol, 3 g) in DMF (20 mL), HATU (0.015
mol, 5.9 g) was added. To this solution, DIPEA (0.022 mol, 2.92 g)
and varying quantity of amine derivatives (A2 to A10) (0.011 mol)
ranging from 0.9 g to 1.8 g was added. The resulting mixture was stirred
at room temperature for 24 h. Upon completion, water was added and
the reaction mixture was extracted thrice with 50 mL of ethyl acetate.
The organic layer was separated and washed with brine, dried over
anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness
and purified using column chromatography to yield the desired compounds,
i.e., [2-((<em>tert</em>-butoxycarbonyl) amino)-<em>N</em>-(substituted)]-3-phenylpropanamide derivatives with the yield of
85% (<strong>KO-A1 to KO-A8</strong>).</p><p class="p p-last">The compounds KO-A2 to KO-A10
were taken to a 25 mL reaction flask, dissolved in DMF (10 mL) and
stirred in an ice bath. Trifluoroacetic acid (0.005 mol, 0.57g) was
added dropwise and then moved to room temperature for 3 h. Completion
of the reaction was confirmed by TLC. The solvent was evaporated by
rotary evaporation, and the product 2-amino-<em>N</em>-(substituted)-3-phenyl
propanamide derivatives (<strong>KO-A1-D to KO-A8-D</strong>) was obtained
and the residue was purified via column chromatography to afford a
compound with the yield of 90%.<sup><a href="#ref18" rid="ref18" class=" bibr popnode">18</a></sup></p></div><div id="sec4.2.3" class="sec sec-last"><p></p><h4 id="sec4.2.3title" class="inline">4.2.3.  General Procedure for the Synthesis of Target
Compounds, i.e., <em>N</em>-Substituted [4-(trifluoro methyl)-1<em>H</em>-imidazole-1-yl] Amide Derivative (<strong>AA1</strong>&#x02013;<strong>AA8</strong>) </h4><p class="p p-first">[4-(Trifluoromethyl)-1<em>H</em>-imidazole-1-yl]
acetic acid (4) (0.0012 mol, 0.25 g) and HATU (0.0012 mol, 0.46 g)
were dissolved in DMF (80 mL) to which sodium carbonate (0.0025 mol,
0.27 g) and varying quantity of 2-amino-<em>N</em>-(substituted)-3-phenylpropanamide
derivatives (KO-A1-D to KO-A8-D) (0.0015 moles) ranging from 0.27
to 0.36 g was added. The reaction mixture was stirred for 24 h at
room temperature. Water (100 mL) was added after the completion of
the reaction and the reaction mixture was extracted with ethyl acetate
(3 &#x000d7; 30 mL). The organic layer was separated and washed with
aqueous NaOH, HCl, and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to yield the crude product (<strong>AA1</strong> to <strong>AA8</strong>). The crude product was purified by column chromatography
and confirmed by <sup>1</sup>H NMR and <sup>13</sup>C NMR, FTIR, and
mass spectroscopy.</p><div id="sec4.2.3.1" class="sec"><p></p><h5 id="sec4.2.3.1title" class="inline">4.2.3.1.  4-Methoxy-3-(3-phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl)acetamido) Propanamido) Benzamide (<strong>AA1</strong>) </h5><p class="p p-first">The title compound (<strong>AA1</strong>) was synthesized
according to the general procedure using 0.365 g of 3-(2-amino-3-phenylpropanamido)-4-methoxybenzamide
(KO-A1-D).</p><p class="p p-last">White powder, yield: 78%, mp: 343.3 &#x000b0;C. IR (KBr):
&#x003bd; (cm<sup>&#x02013;1</sup>) 3291 (N&#x02013;H<sub>str</sub>),
1647 (C=O), 1576 (C=N Imidazole), 1118 (C&#x02013;O). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 9.51 (s, 1<em>H</em>, Amide-<em>H</em>), 8.76
(d, <em>J</em> = 8.3 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 8.34 (s, 1H, Amide-<em>H</em>), 7.83 (s, 1H,
Imidazole&#x02013;<em>H</em>), 7.66 (m, 2H, Ar&#x02013;<em>H</em>), 7.56 (s, 1H, Imidazole&#x02013;<em>H</em>), 7.32
(d, <em>J</em> = 7.1 Hz, 2H, Ar&#x02013;<em>H</em>),
7.27 (t, <em>J</em> = 7.5 Hz, 2H, Amide-<em>H</em>), 7.22&#x02013;7.16 (m, 2H, Ar&#x02013;<em>H</em>), 7.07 (d, <em>J</em> = 8.6 Hz, 1H, Ar&#x02013;<em>H</em>), 4.88 (d, <em>J</em> = 4.4 Hz, 1H, &#x02212;CH&#x02013; between two amides),
4.74 (q, <em>J</em> = 16.3 Hz, 2H, &#x02212;CH<sub>2</sub>&#x02013;
attached to imidazole), 3.85 (s, 3H, &#x02212;OCH<sub>3</sub>), 3.12
(dd, <em>J</em> = 13.5, 4.4 Hz, 1H of &#x02212;CH<strong>H</strong>&#x02013; attached to benzene), 2.87 (dd, <em>J</em> = 13.4,
9.8 Hz, 1H of &#x02212;C<strong>H</strong>H&#x02013; attached to benzene). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 170.34 (Amide-C), 167.93 (Amide-C), 166.68 (Amide-C), 153.00
(Ar&#x02013;C), 140.29 (Imidazole&#x02013;C), 137.89 (Imidazole&#x02013;CH),
129.81 (Ar&#x02013;C), 129.09 (Ar&#x02013;CH), 128.55 (Ar&#x02013;CH),
128.12 (Ar&#x02013;CH), 126.87 (Ar&#x02013;C), 126.70 (Ar&#x02013;C),
124.98 (Ar&#x02013;CH), 123.18 (Ar&#x02013;C), 121.93 (CF<sub>3</sub>), 112.77 (Imidazole&#x02013;CH), 110.91 (Ar&#x02013;CH), 56.46 (Aliphatic-C,
&#x02212;CH&#x02013; between two amides), 55.08 (&#x02212;OCH<sub>3</sub>), 49.22 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached to
benzene), 38.26 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached
to Imidazole). ESI-MS (<em>m</em>/<em>z</em>): 490.16
[M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.2" class="sec"><p></p><h5 id="sec4.2.3.2title" class="inline">4.2.3.2.  <em>N</em>-(3-Fluoro-4-methylphenyl)-3-Phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl) Acetamido) Propenamide (<strong>AA2</strong>) </h5><p class="p p-first">Compound <strong>AA2</strong> was synthesized from a general
procedure using 0.315 g of 2-amino-<em>N</em>-(4-fluoro-3-methyl
phenyl)-3-phenylpropanamide (<strong>KO-A2-D</strong>).</p><p class="p p-last">Cream color
powder, yield: 82%. mp: 342.5 &#x000b0;C, IR (KBr): &#x003bd; (cm<sup>&#x02013;1</sup>) 3291 (N&#x02013;H<sub>str</sub>), 1651 (C=O), 1543 (C=N
Imidazole), 1412 (C&#x02013;H). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm) 10.28 (s, 1<em>H</em>, Ar&#x02013;<em>H</em>), 8.81 (d, <em>J</em> = 8.1
Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.69 (s, 1<em>H</em>, Amide-<em>H</em>), 7.59 (s, 1<em>H</em>, Amide-<em>H</em>), 7.49 (m, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.27 (s, 1H, Imidazole&#x02013;<em>H</em>), 7.25
(m, 3<em>H</em>), 7.20 (dd, <em>J</em> = 5.5, 2.9
Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.18 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.15 (dd, <em>J</em> = 8.2, 1.9 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 4.76 (q, <em>J</em> = 16.4 Hz, 2<em>H</em>, &#x02212;CH<sub>2</sub>&#x02013; attached to Imidazole), 4.67 (dt, <em>J</em> = 14.0, 7.2 Hz, 1<em>H</em>, &#x02212;CH&#x02013;
between two amides), 3.05 (dd, <em>J</em> = 13.7, 5.5 Hz,
1<em>H</em> of CH<strong>H</strong> attached to benzene), 2.87
(dd, <em>J</em> = 13.7, 9.1 Hz, 1H of C<strong>H</strong>H attached
to benzene), 2.16 (s, 3<em>H</em>, &#x02212;CH<sub>3</sub>). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 170.18 (Amide-C), 166.61 (Amide-C), 161.61 (Ar&#x02013;C), 159.69
(Ar&#x02013;C), 140.33 (Imidazole&#x02013;C), 138.45 (Ar&#x02013;C),
138.36 (Ar&#x02013;CH), 137.62 (Imidazole&#x02013;CH), 131.94 (Ar&#x02013;CH),
131.89 (Ar&#x02013;CH), 129.68 (Ar&#x02013;CH), 128.64 (Ar&#x02013;CH),
128.52 (Ar&#x02013;CH), 126.99 (Ar&#x02013;CH), 121.96 (CF3), 119.24
(Imidazole&#x02013;CH), 115.43 (Ar&#x02013;C), 106.65 (Ar&#x02013;CH),
55.44 (Aliphatic-C, &#x02212;CH&#x02013; between two amides), 49.19
(Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached to benzene),
38.45 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached to Imidazole),
14.12 (&#x02212;CH<sub>3</sub>). ESI-MS (<em>m</em>/<em>z</em>): 449.15[M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.3" class="sec"><p></p><h5 id="sec4.2.3.3title" class="inline">4.2.3.3.  <em>N</em>-(3-Ethylphenyl)-3-phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl)acetamido) Propenamide (<strong>AA3</strong>) </h5><p class="p p-first">Compound <strong>AA3</strong> was obtained according to the
described general procedure using 0.310 g of 2-amino-<em>N</em>-(3-ethylphenyl)-3-phenylpropanamide (<strong>KO-A3-D</strong>).</p><p class="p p-last">Cream color powder, yield: 88%, mp: 340.3 &#x000b0;C. IR (KBr): &#x003bd;
(cm<sup>&#x02013;1</sup>) 3276 (N&#x02013;H<sub>str</sub>), 1647 (C=O),
1535 (C=N Imidazole), 2922, 3026 (C&#x02013;H<sub>str</sub> Aliphatic). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 10.11 (s, 1H, Amide-<em>H</em>), 8.77 (d, <em>J</em> = 8.2 Hz, 1H, Ar&#x02013;<em>H</em>), 7.69 (s, 1<em>H</em>, Amide-H), 7.59 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.40&#x02013;7.38 (m, 2<em>H</em>, Ar&#x02013;<em>H</em>), 7.27 (d, <em>J</em> = 4.4 Hz, 4<em>H</em>, Ar&#x02013;<em>H</em>), 7.20 (dd, <em>J</em> = 8.1,
3.2 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.18 (s,
1<em>H</em>, Imidazole&#x02013;<em>H</em>), 6.90 (d, <em>J</em> = 7.7 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 4.76 (q, <em>J</em> = 16.4 Hz, 2<em>H</em>, &#x02212;CH<sub>2</sub>&#x02013; attached to Imidazole), 4.69 (m, 1<em>H</em>, &#x02212;CH&#x02013; between two amides), 3.07 (dd, <em>J</em> = 13.7, 5.3 Hz, 1<em>H</em> of &#x02212;CH<strong>H</strong>&#x02013;
attached to benzene), 2.87 (m, 1<em>H</em> of &#x02212;C<strong>H</strong>H&#x02013; attached to benzene), 2.56 (q, <em>J</em> = 7.6 Hz, 2<em>H</em>, &#x02212;C<strong>H</strong><sub><strong>2</strong></sub>CH<sub>3</sub>), 1.15 (t, <em>J</em> = 7.6
Hz, 3<em>H</em>, &#x02212;CH<sub>2</sub>C<strong>H</strong><sub><strong>3</strong></sub>). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm): 169.98 (Amide-C), 166.56
(Amide-C), 144.74 (Ar&#x02013;C), 140.32 (Imidazole&#x02013;C), 139.12
(Ar&#x02013;C), 137.78 (Imidazole&#x02013;CH), 129.70 (Ar&#x02013;C),
129.11 (Ar&#x02013;CH), 128.62 (Ar&#x02013;CH), 126.94 (Ar&#x02013;CH),
123.56 (Ar&#x02013;CH), 121.97 (CF3), 121.94 (Ar&#x02013;CH), 119.25
(Imidazole&#x02013;CH), 117.38 (Ar&#x02013;CH), 117.29 (Ar&#x02013;CH),
55.45 (Aliphatic-C, &#x02212;CH&#x02013; between two amides), 49.22
(Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached to benzene),
38.49 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached to Imidazole),
28.69 (&#x02212;<strong>C</strong>H<sub>2</sub>CH<sub>3</sub>), 15.95 (&#x02212;CH<sub>2</sub><strong>C</strong>H<sub>3</sub>). ESI-MS (<em>m</em>/<em>z</em>): 445.18 [M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.4" class="sec"><p></p><h5 id="sec4.2.3.4title" class="inline">4.2.3.4.  <em>N</em>-(2,3-Dimethylphenyl)-3-phenyl-2-(2-(4-(trifluoromethyl)-1H-imidazole-1-yl)acetamido)
Propenamide (<strong>AA4</strong>) </h5><p class="p p-first">Compound <strong>AA4</strong> was
synthesized from a general procedure using 0.310 g of 2-amino-<em>N</em>-(2,3-dimethylphenyl)-3-phenylpropanamide (<strong>KO-A4-D</strong>).</p><p class="p p-last">Purple color powder, yield: 80%, mp: 351.9 &#x000b0;C, IR (KBr):
&#x003bd; (cm<sup>&#x02013;1</sup>) 3272 (N&#x02013;H<sub>str</sub>),
1647 (C=O), 1446 (C=N Imidazole), 2922 (C&#x02013;H<sub>str</sub> Aliphatic). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm): 9.58 (s, 1<em>H</em>, Amide-<em>H</em>), 8.77 (d, <em>J</em> = 8.2 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.70 (s, 1<em>H</em>, Amide-<em>H</em>), 7.59 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.29 (d, <em>J</em> = 4.4 Hz, 4<em>H</em>, Ar&#x02013;<em>H</em>), 7.22 (dd, <em>J</em> = 8.8,
4.5 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.02 (m,
2<em>H</em>, Ar&#x02013;<em>H</em>), 7.01 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 4.80 (d, <em>J</em> = 16.4 Hz, 1<em>H</em>, &#x02212;CH&#x02013; between
two amides), 4.75 (t, <em>J</em> = 9.8 Hz, 2<em>H</em>, &#x02212;CH2&#x02013; attached to imidazole), 3.11 (dd, <em>J</em> = 13.5, 5.8 Hz, 1<em>H</em> of &#x02212;CH<strong>H</strong>&#x02013;
attached to benzene), 2.96&#x02013;2.87 (m, 1<em>H</em> of
&#x02212;C<strong>H</strong>H&#x02013; attached to benzene), 2.21 (s, 3<em>H</em>, &#x02212;CH<sub>3</sub>, attached to benzene), 1.93 (s,
3<em>H</em>, &#x02212;CH<sub>3</sub>, attached to benzene). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 170.02 (Amide-C), 166.57 (Amide-C), 140.31 (Ar&#x02013;C), 137.83
(Imidazole&#x02013;C), 137.44 (Ar&#x02013;C), 135.99 (Imidazole&#x02013;CH),
131.98 (Ar&#x02013;C), 129.78 (Ar&#x02013;C), 128.64 (Ar&#x02013;C),
127.66 (Ar&#x02013;C), 126.94 (Ar&#x02013;C), 125.61 (Ar&#x02013;C),
124.20 (Ar&#x02013;C), 123.95 (Ar&#x02013;C), 121.94 (CF<sub>3</sub>), 121.91 (Imidazole&#x02013;CH), 55.04 (Aliphatic-C, &#x02212;CH&#x02013;
between two amides), 49.32 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013;
attached to benzene), 38.60 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013;
attached to Imidazole), 20.56 (&#x02212;CH<sub>3</sub>&#x02013; attached
to benzene), 14.30 (&#x02212;CH<sub>3</sub>&#x02013; attached to benzene).
ESI-MS (<em>m</em>/<em>z</em>): 445.18[M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.5" class="sec"><p></p><h5 id="sec4.2.3.5title" class="inline">4.2.3.5.  <em>N</em>-Cyclopentyl-3-phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl)acetamido) Propenamide (<strong>AA5</strong>) </h5><p class="p p-first">The titled compound <strong>AA5</strong> was synthesized according
to the general procedure from 0.270 g of 2-amino-<em>N</em>-cyclopentyl-3-phenylpropanamide (<strong>KO-A5-D</strong>).</p><p class="p p-last">White
color powder, yield: 88%, mp: 365.9 &#x000b0;C, IR (KBr): &#x003bd; (cm<sup>&#x02013;1</sup>) 3280 (N&#x02013;H<sub>str</sub>), 1640 (C=O),
1669 (C=N Imidazole), 2870, 2952 (C&#x02013;H<sub>str</sub> Aliphatic). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 8.63 (s, 1<em>H</em>, Amide-<em>H</em>), 8.03
(d, <em>J</em> = 7.1 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.68 (s, 1<em>H</em>, Amide-<em>H</em>), 7.57 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.25 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.23 (d, <em>J</em> = 7.3 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.18 (dd, <em>J</em> = 13.8, 6.9 Hz, 3<em>H</em>, Ar&#x02013;<em>H</em>), 4.73 (q, <em>J</em> = 16.3 Hz, 2<em>H</em>, &#x02212;CH<sub>2</sub>&#x02013; attached
to imidazole), 4.48 (dd, <em>J</em> = 14.5, 8.4 Hz, 1<em>H</em>, &#x02212;CH&#x02013; between two amides), 3.94 (dt, <em>J</em> = 13.5, 6.8 Hz, 1<em>H</em> of cyclopentyl ring),
2.91 (m, 1<em>H</em> of &#x02212;CH<strong>H</strong>&#x02013; attached
to benzene), 2.77 (dd, <em>J</em> = 13.4, 8.6 Hz, 1<em>H</em> of &#x02212;C<strong>H</strong>H&#x02013; attached to benzene),
1.78&#x02013;1.62 (m, 2<em>H</em> of cyclopentyl ring), 1.62&#x02013;1.47
(m, 2<em>H</em> of cyclopentyl ring), 1.47&#x02013;1.32 (m,
3<em>H</em> of cyclopentyl ring), 1.32&#x02013;1.16 (m, 1<em>H</em> of cyclopentyl ring). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm): 170.26 (Amide-C), 166.20
(Amide-C), 162.81 (Ar&#x02013;C), 140.25 (Ar&#x02013;CH), 137.96 (Imidazole&#x02013;C),
129.73 (Imidazole&#x02013;CH), 128.46 (Ar&#x02013;CH), 126.75 (Ar&#x02013;CH),
121.87 (CF<sub>3</sub>), 121.84 (Imidazole&#x02013;CH), 54.73 (Aliphatic-C,
&#x02212;CH&#x02013; between two amides), 50.71 (&#x02212;C of cyclopentyl
ring), 49.35 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached
to benzene), 38.87 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached
to Imidazole), 32.66 (&#x02212;CH of cyclopentyl ring), 32.36 (&#x02212;CH
of cyclopentyl ring), 23.88 (&#x02212;CH of cyclopentyl ring), 23.82
(&#x02212;CH of cyclopentyl ring). ESI-MS (<em>m</em>/<em>z</em>): 409 [M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.6" class="sec"><p></p><h5 id="sec4.2.3.6title" class="inline">4.2.3.6.  <em>N</em>-(2,4-Dimethylphenyl)-3-phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl)acetamido) Propenamide (<strong>AA6</strong>) </h5><p class="p p-first">Compound <strong>AA6</strong> was obtained according to the
described general procedure using 0.311 g of 2-amino-<em>N</em>-(2,4-dimethyl phenyl)-3-phenylpropanamide (<strong>KO-A6-D</strong>).</p><p class="p p-last">Cream color flake, yield: 92%, mp: 356.4 &#x000b0;C, IR (KBr): &#x003bd;
(cm<sup>&#x02013;1</sup>) 3272 (N&#x02013;H<sub>str</sub>), 1647 (C=O),
1559 (C=N Imidazole), 2922 (C&#x02013;H<sub>str</sub> Aliphatic). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 9.45 (s, 1<em>H</em>, Amide-<em>H</em>), 8.76
(d, J = 8.2 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>),
7.70 (s, 1<em>H</em>, Amide-<em>H</em>), 7.59 (s,
1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.28 (d, <em>J</em> = 4.7 Hz, 4<em>H</em>, Ar&#x02013;<em>H</em>), 7.23&#x02013;7.19 (m, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.11 (d, <em>J</em> = 8.0 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 6.99 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 6.94 (d, <em>J</em> = 8.1 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 4.79 (d, <em>J</em> = 16.3
Hz, 1<em>H</em>, &#x02212;CH between two amides), 4.74 (m,
2<em>H</em>, &#x02212;CH<sub>2</sub>&#x02013; attached to imidazole),
3.10 (dd, <em>J</em> = 13.6, 5.8 Hz, 1<em>H</em> of
&#x02212;CH<strong>H</strong>&#x02013; attached to benzene), 2.90 (m, 1<em>H</em> of &#x02212;C<strong>H</strong>H&#x02013; attached to benzene),
2.23 (s, 3<em>H</em>, CH<sub>3</sub> attached to benzene),
2.00 (s, 3<em>H</em>, CH<sub>3</sub> attached to benzene). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 169.91 (Amide-C), 166.55 (Amide-C), 140.31 (Ar&#x02013;C), 137.83
(Imidazole&#x02013;C), 135.11 (Ar&#x02013;C), 133.58 (Imidazole&#x02013;CH),
132.61 (Ar&#x02013;C), 131.26 (Ar&#x02013;CH), 129.77 (Ar&#x02013;CH),
128.63 (Ar&#x02013;CH), 126.93 (Ar&#x02013;CH), 126.88 (Ar&#x02013;CH),
125.82 (Ar&#x02013;CH), 125.74 (Ar&#x02013;CH), 121.93 (Imidazole&#x02013;CH),
121.90 (CF<sub>3</sub>), 55.00 (Aliphatic-C, &#x02212;CH&#x02013; between
two amides), 49.31 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached
to benzene), 38.66 (Aliphatic-C, &#x02212;CH<sub>2</sub>&#x02013; attached
to Imidazole), 20.94 (CH<sub>3</sub> attached to benzene), 18.01 (CH<sub>3</sub> attached to benzene). ESI-MS (<em>m</em>/<em>z</em>): 446.18 [M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.7" class="sec"><p></p><h5 id="sec4.2.3.7title" class="inline">4.2.3.7.  <em>N</em>-(2-Methoxyphenyl)-3-phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl)acetamido) Propenamide (<strong>AA7</strong>) </h5><p class="p p-first">Compound <strong>AA7</strong> was obtained according to the
described general procedure using 0.313 g of 2-amino-<em>N</em>-(2-methoxyphenyl)-3-phenylpropanamide (<strong>KO-A7-D</strong>).</p><p class="p p-last">Cream color powder, yield: 95%, mp: 341.7 &#x000b0;C, IR (KBr): &#x003bd;
(cm<sup>&#x02013;1</sup>) 3265 (N&#x02013;H<sub>str</sub>), 1647 (C=O),
1539 (C=N Imidazole), 2937 (C&#x02013;H<sub>str</sub> Aliphatic),
1114 (C&#x02013;O). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm): 9.40 (s, 1<em>H</em>, Amide-<em>H</em>), 8.74 (d, <em>J</em> = 8.3 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.87 (dd, <em>J</em> = 7.9,
1.4 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.68 (s,
1<em>H</em>, Amide-<em>H</em>), 7.56 (s, 1<em>H</em>, imidazole&#x02013;<em>H</em>), 7.30 (t, <em>J</em> = 7.8 Hz, 3<em>H</em>, Ar&#x02013;<em>H</em>), 7.26 (d, <em>J</em> = 7.7 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.19 (t, <em>J</em> = 7.1 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.08 (m, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.03 (dd, <em>J</em> = 8.2, 1.3 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 6.90 (s, 1<em>H</em>, imidazole&#x02013;<em>H</em>), 4.89 (td, <em>J</em> = 9.0, 4.9 Hz, 1<em>H</em>, &#x02212;CH&#x02013; between two
amides), 4.74 (q, <em>J</em> = 16.3 Hz, 2<em>H</em>, &#x02212;CH<sub>2</sub>&#x02013; attached to imidazole), 3.80 (s,
3<em>H</em>, O&#x02013;CH<sub>3</sub>), 3.11 (dd, <em>J</em> = 13.7, 4.8 Hz, 1<em>H</em> of &#x02212;CH<strong>H</strong>&#x02013;
attached to benzene), 2.87 (dd, <em>J</em> = 13.7, 9.6 Hz,
1<em>H</em> of &#x02212;C<strong>H</strong>H&#x02013; attached to
benzene). <sup>13</sup>C NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm): 170.18 (Amide-C), 166.66 (Amide-C), 150.34
(Ar&#x02013;C), 140.29 (Ar&#x02013;C), 137.88 (Imidazole&#x02013;C),
129.83 (Imidazole&#x02013;CH), 128.54 (Ar&#x02013;CH), 127.22 (Ar&#x02013;CH),
126.86 (Ar&#x02013;CH), 125.28 (Ar&#x02013;CH), 122.61 (Ar&#x02013;CH),
121.91 (CF<sub>3</sub>), 121.88 (Ar&#x02013;CH), 121.50 (Ar&#x02013;CH),
120.70 (Ar&#x02013;CH), 111.75 (Imidazole&#x02013;CH), 56.16 (OCH<sub>3</sub>), 55.09 (Aliphatic-C, &#x02212;CH&#x02013; between two amides),
49.24 (Aliphatic-C, attached to benzene), 38.26 (Aliphatic-C, attached
to Imidazole). ESI-MS (<em>m</em>/<em>z</em>): 447.16
[M + H]<sup>+</sup>.</p></div><div id="sec4.2.3.8" class="sec sec-last"><p></p><h5 id="sec4.2.3.8title" class="inline">4.2.3.8.  <em>N</em>-(2,5-Dimethylphenyl)-3-phenyl-2-(2-(4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl)acetamido) Propenamide (<strong>AA8</strong>) </h5><p class="p p-first">Compound <strong>AA8</strong> was obtained according to the
described general procedure using 0.311 g of 2-amino-<em>N</em>-(2,5-dimethyl phenyl)-3-phenyl propanamide (<strong>KO-A8-D</strong>).</p><p class="p p-last">White powder, yield: 80%, mp: 353.6 &#x000b0;C, IR (KBr): &#x003bd;
(cm<sup>&#x02013;1</sup>) 3272 (N&#x02013;H<sub>str</sub>), 1647 (C=O),
1535 (C=N Imidazole), 3026, 2922 (C&#x02013;H<sub>str</sub> Aliphatic). <sup>1</sup>H NMR (500 MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4;
(ppm): 9.52 (s, 1<em>H</em>, Amide-<em>H</em>), 8.78
(d, <em>J</em> = 8.2 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.94 (s, 1<em>H</em>, Imidazole&#x02013;<em>H</em>), 7.71 (s, 1<em>H</em>, Amide-<em>H</em>), 7.60 (d, <em>J</em> = 1.1 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.29 (d, <em>J</em> = 4.3 Hz, 4<em>H</em>, Ar&#x02013;<em>H</em>), 7.25 (s, 1<em>H</em>. imidazole&#x02013;<em>H</em>), 7.22 (dd, <em>J</em> = 8.9, 4.4 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.18 (d, <em>J</em> = 7.6 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.15
(t, <em>J</em> = 7.5 Hz, 1<em>H</em>, Ar&#x02013;<em>H</em>), 7.08 (m, 1<em>H</em>, Ar&#x02013;<em>H</em>), 4.79 (d, <em>J</em> = 9.3 Hz, 1<em>H</em>, &#x02212;CH&#x02013;
between two amides), 4.76 (dd, <em>J</em> = 12.8, 9.5 Hz,
2<em>H</em> of &#x02212;CH<sub>2</sub> attached to imidazole),
3.11 (dd, <em>J</em> = 13.6, 5.8 Hz, 1<em>H</em> of
&#x02212;CH<strong>H</strong>&#x02013; attached to benzene), 2.92 (dd, <em>J</em> = 13.5, 8.9 Hz, 1<em>H</em> of &#x02212;C<strong>H</strong>H&#x02013; attached to benzene), 2.05 (s, 3<em>H</em>, &#x02212;CH<sub>3</sub> attached to benzene). <sup>13</sup>C NMR
(500MHz, DMSO-<em>d</em><sub>6</sub>): &#x003b4; (ppm): 170.01
(Amide-C), 166.64 (Amide-C), 162.85 (Ar&#x02013;C), 140.30, 137.79
(Imidazole&#x02013;C), 136.16 (Ar&#x02013;C), 132.74 (Imidazole&#x02013;C),
130.75 (Ar&#x02013;C), 129.76 (Ar&#x02013;CH), 128.64 (Ar&#x02013;CH),
126.95 (Ar&#x02013;CH), 126.37 (Ar&#x02013;CH), 126.04 (Ar&#x02013;CH),
125.83 (Ar&#x02013;CH), 121.91 (CF<sub>3</sub>), 121.87 (Imidazole&#x02013;C),
55.16 (Aliphatic-C, between two amides), 49.31 (Aliphatic-C, attached
to benzene), 38.52 (Aliphatic-C, attached to Imidazole), 18.04 (CH<sub>3</sub> attached to benzene). ESI-MS (<em>m</em>/<em>z</em>): 445.18 [M + H]<sup>+</sup>.</p></div></div></div><div id="sec4.3" class="sec"><h3 id="sec4.3title">4.3. In Vitro Anti-Inflammatory Activity</h3><div id="sec4.3.1" class="sec sec-first"><p></p><h4 id="sec4.3.1title" class="inline">4.3.1.  Evaluation of Albumin Denaturation Inhibitory
Activity of Synthesized Compounds </h4><p class="p p-first-last">The denaturation of proteins
is one of the most well-known causes of inflammation. As part of the
investigation, eight test samples AA1&#x02013;AA8 were evaluated for
their anti-inflammatory properties. The protein denaturation assay
was performed.<sup><a href="#ref19" rid="ref19" class=" bibr popnode">19</a></sup> Various concentrations
of test samples were prepared at 100, 200, and 300 &#x003bc;g/mL, and
each reaction mixture was prepared by mixing with 0.5 mL of 1.5 mg/mL
bovine serum albumin (BSA) and incubating at 37 &#x000b0;C for 20 min.
The reaction mixtures were then heated for 3 min at 57 &#x000b0;C. Phosphate
buffer (0.5 M, pH 6.3) with a volume of 250 &#x003bc;L was added to
each mixture, which was thoroughly mixed. Then, after equal distribution
of molecules in each reaction mixture, 100 &#x003bc;L of each mixture
was transferred into separate test tubes, and Folin&#x02013;Ciocalteu&#x02019;s
reagent was added in the same proportion by volume. After 10 min of
incubation at 55 &#x000b0;C, the tubes were allowed to cool, and absorbance
was determined at the wavelength of 650 nm using a Multimode Microplate
Reader (Tecan Sunrise, USA). Diclofenac sodium (100 &#x003bc;g/mL) was
used to evaluate the recorded measurements as a reference drug. The
inhibition percentage of protein denaturation was calculated using
the following formula</p><div class="disp-formula" id="ueq1"><div class="f"><img loading="lazy" src="/pmc/articles/PMC10210024/bin/ao3c00605_m001.jpg" class="eq-image" alt="equation image" title="equation image" /></div></div><p></p></div><div id="sec4.3.2" class="sec sec-last"><p></p><h4 id="sec4.3.2title" class="inline">4.3.2.  Evaluation of In Vitro p38 MAP Kinase Inhibitory
Assay for the Synthesized Compounds </h4><p class="p p-first-last">In the present study,
a nonradioactive immunosorbent assay for p38 kinase activity has been
used, which can be used routinely for the screening of small-molecule
inhibitors of p38 kinase. An ATF-2 substrate was used for phosphorylation,
which showed linearity between 5-30 ng/well. Based on this analysis,
15 ng/well at a 1.5 h incubation period was determined to be optimal.
The p38 kinase substrate ATF-2 (10 &#x003bc;g/mL in TBS) was coated
onto microtiter plates for 1.5 h at 37 &#x000b0;C. The remaining open
binding sites were blocked with blocking buffer (BB; 0.05% Tween 20,
0.25% BSA, 0.02% NaN<sub>3</sub> in TBS) for 30 min at room temperature,
following three washings with distilled water. The plates were then
washed again, and the plates were incubated at 37 &#x000b0;C for 1 h.
Test solutions such as AA2, AA3, AA4, AA5, and AA6 containing 15 ng/well
p38 MAPK were diluted in kinase buffer (50 mM Tris, pH 7.5, 10 mM
MgCl<sub>2</sub>, 10 mM &#x003b2;-glycerophosphate, 100 &#x003bc;g/mL
BSA, 1mM dithiothreitol, 0.1 mM Na<sub>3</sub>VO<sub>4</sub>, and
100 &#x003bc;g/mL rATP), with or without test substance (ranging from
0.01 to 1.0 &#x003bc;M). After the subsequent washing, plates were blocked
with BB for 15 min and washed four times. Wells were filled with 50
&#x003bc;L of the specific anti-bis-(Thr<sup>69/71</sup>)-phospho-ATF-2
(AB, 1:500 in BB) and incubated for 1 h at 37 &#x000b0;C followed by
washing and consecutive incubation with 50 &#x003bc;L of the secondary
antibody [AB (alkaline phosphatase-conjugated), 1:1400 in BB]. Then,
100 &#x003bc;L of 4-NPP was pipetted in each well after a final washing
step, and color development was measured 1.5&#x02013;2 h later with
an enzyme-linked immunosorbent assay reader at 405 nm (Tecan, Sunrise,
USA). Percent enzyme activity and IC<sub>50</sub> were calculated
based on the kinase measurement values using megalin software 4.21.</p></div></div><div id="sec4.4" class="sec"><h3 id="sec4.4title">4.4. Molecular Docking of <em>N</em>-Substituted
[4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl] Amide Derivative</h3><p class="p p-first">Molecular docking studies were done in AutoDock 4.2. The docking
study was performed in order to investigate the binding ability of
the novel <em>N</em>-substituted [4-(trifluoromethyl)-1<em>H</em>-imidazole-1-yl] amide derivative to the binding site of
the p38&#x003b1; MAP kinase protein. The docking scores were found out.</p><div id="sec4.4.1" class="sec"><p></p><h4 id="sec4.4.1title" class="inline">4.4.1.  Protein Preparation </h4><p class="p p-first-last">The protein
3D crystal structure of p38&#x003b1; MAP kinase (PDB: <a href="https://www.rcsb.org/structure/1A9U" data-ga-action="click_feat_suppl" ref="reftype=extlink-pdb&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CPDB" target="_blank">1A9U</a>, resolution: 2.50
&#x000c5;) was retrieved in PDB format from the Protein Data Bank (PDB),
and the 3D protein structure was refined and energy minimized before
docking analysis. Missing atoms, polar hydrogens, and Kollman charges
were added to refine the protein, whereas crystallographic water molecules,
foreign ligands, and unnecessary ions were deleted. The docking procedure
involved the employment of a flexible ligand and a rigid protein.</p></div><div id="sec4.4.2" class="sec"><p></p><h4 id="sec4.4.2title" class="inline">4.4.2.  Ligand Preparation </h4><p class="p p-first-last">The 3D structure
of the proposed ligands was drawn using ACD Lab Chemsketch and saved
in mol 2 molecular format. These mol 2 structures were converted into
pdbqt format using MGL tools 1.5.7.</p></div><div id="sec4.4.3" class="sec sec-last"><p></p><h4 id="sec4.4.3title" class="inline">4.4.3.  Docking </h4><p class="p p-first-last">Docking studies were performed
with AutoDock 4.2 using the Lamarckian genetic algorithm. The flexible
docking procedure was used for a p38&#x003b1; MAP kinase protein and
a flexible ligand. A grid of 60, 60, and 60 points was created in
the x, y, and z directions. A grid spacing of 0.375 &#x000c5; using Autogrid
Grid 4 and a distance-dependent function of the dielectric constant
were used for the calculation of the energy map. The default settings
were used for all other parameters. At the end of docking, the ligand
with the most favorable free energy of binding was noted. Each molecule
was docked using AutoDock 4.2 with parameters ga_num_evals and ga_run
set to 25&#x02009;000&#x02009;000 and 50, respectively, as suggested.
Molecular interaction diagrams are obtained from DS 4.0 visualizer.
The entire calculations were carried out on PC-based machines running
Linux as an operating system.<sup><a href="#ref20" rid="ref20" class=" bibr popnode">20</a></sup></p></div></div><div id="sec4.5" class="sec sec-last"><h3 id="sec4.5title">4.5. ADME Studies</h3><p class="p p-first-last">The ADME (absorption,
distribution, metabolism, and excretion) properties of compounds were
assessed using Swiss ADME software. According to Lipinski&#x02019;s
rule of five, compounds observed good oral bioavailability if the
compound&#x02019;s molecular weight is &#x0003c; 500. All compounds followed
the rule. The gastrointestinal safety profile was also performed using
Swiss ADME software. The list of SMILES was uploaded on these online
web servers, and the required attributes of the desired compounds
were created.<sup><a href="#ref21" rid="ref21" class=" bibr popnode">21</a></sup></p></div></div><div id="ack-a.ab.d" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.ab.dtitle">Acknowledgments</h2><div class="sec"><p>Authors are thankful to Sri Venkateshwara College
of Pharmacy, Surabhi Educational Society, Hyderabad and the Faculty
of Pharmacy, Integral University, Lucknow for its research atmosphere,
motivation to do research work, and providing necessary facilities
to do the work (Manuscript Communication Number: IU/R&#x00026;D/2023-MCN0001909).</p></div></div><div id="notes1" class="tsec sec"><h2 class="head no_bottom_margin" id="notes1title">Supporting Information Available</h2><p>The Supporting Information
is
available free of charge at <a href="https://pubs.acs.org/doi/10.1021/acsomega.3c00605?goto=supporting-info" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://pubs.acs.org/doi/10.1021/acsomega.3c00605</a>.</p><ul class="simple" style="list-style-type:none" id="silist"><li><div>FTIR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, and MS
spectra of the final compounds; <sup>1</sup>H NMR of intermediate
compounds; and docking structures of the final compounds (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.3c00605/suppl_file/ao3c00605_si_001.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">PDF</a>)</div></li></ul><p></p></div><div id="NOTES-d14e2474-autogenerated" class="tsec sec"><h2 class="head no_bottom_margin" id="NOTES-d14e2474-autogeneratedtitle">Notes</h2><p>The
authors declare no
competing financial interest.</p></div><div id="sec-a.ab.b" class="tsec bk-sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.ab.btitle">Supplementary Material</h2><!--/article/back/sec/--><div class="sec suppmat" id="sifile1"><div class="sup-box half_rhythm" id="media-a.ab.b.b.a"><a href="/pmc/articles/PMC10210024/bin/ao3c00605_si_001.pdf" data-ga-action="click_feat_suppl">ao3c00605_si_001.pdf</a><sup>(2.6M, pdf)</sup></div></div></div><div id="ref-list-a.ab.e" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.ab.etitle">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="ref1"><span class="mixed-citation" id="cit1">Yang G.; Chang C. C.; Yang Y.; Yuan L.; Xu L.; Ho C. T.; Li S.
<span class="ref-title">Resveratrol Alleviates Rheumatoid
Arthritis via Reducing ROS and Inflammation, Inhibiting MAPK Signaling
Pathways, and Suppressing Angiogenesis</span>. <span class="ref-journal">J. Agric.
Food Chem.</span>
2018, <span class="ref-vol">66</span>, 12953&#x02013;12960. 10.1021/acs.jafc.8b05047. [<a href="https://pubmed.ncbi.nlm.nih.gov/30511573" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1021%2Facs.jafc.8b05047" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Agric.&#10;Food+Chem.&amp;title=Resveratrol+Alleviates+Rheumatoid&#10;Arthritis+via+Reducing+ROS+and+Inflammation,+Inhibiting+MAPK+Signaling&#10;Pathways,+and+Suppressing+Angiogenesis&amp;author=G.+Yang&amp;author=C.+C.+Chang&amp;author=Y.+Yang&amp;author=L.+Yuan&amp;author=L.+Xu&amp;volume=66&amp;publication_year=2018&amp;pages=12953-12960&amp;pmid=30511573&amp;doi=10.1021/acs.jafc.8b05047&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref2"><span class="mixed-citation" id="cit2">Long Y.; Zhao Y.; Ma X.; Zeng Y.; Hu T.; Wu W.; Deng C.; Hu J.; Shen Y.
<span class="ref-title">Endoplasmic reticulum
stress contributed to inflammatory bowel disease by activating p38
MAPK pathway</span>. <span class="ref-journal">Eur. J. Histochem.</span>
2022, <span class="ref-vol">66</span>, 3415. 10.4081/ejh.2022.3415. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9178311/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35603939" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4081%2Fejh.2022.3415" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Histochem.&amp;title=Endoplasmic+reticulum&#10;stress+contributed+to+inflammatory+bowel+disease+by+activating+p38&#10;MAPK+pathway&amp;author=Y.+Long&amp;author=Y.+Zhao&amp;author=X.+Ma&amp;author=Y.+Zeng&amp;author=T.+Hu&amp;volume=66&amp;publication_year=2022&amp;pages=3415&amp;pmid=35603939&amp;doi=10.4081/ejh.2022.3415&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref3"><span class="mixed-citation" id="cit3">Romero-Becerra R.; Santamans A. M.; Folgueira C.; Sabio G.
<span class="ref-title">p38 MAPK Pathway in
the Heart: New Insights in Health and Disease</span>. <span class="ref-journal">Int. J. Mol. Sci.</span>
2020, <span class="ref-vol">21</span>, 7412. 10.3390/ijms21197412. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7582802/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33049962" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms21197412" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=p38+MAPK+Pathway+in&#10;the+Heart:+New+Insights+in+Health+and+Disease&amp;author=R.+Romero-Becerra&amp;author=A.+M.+Santamans&amp;author=C.+Folgueira&amp;author=G.+Sabio&amp;volume=21&amp;publication_year=2020&amp;pages=7412&amp;pmid=33049962&amp;doi=10.3390/ijms21197412&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref4"><span class="mixed-citation" id="cit4">Falcicchia C.; Tozzi F.; Arancio O.; Watterson D. M.; Origlia N.
<span class="ref-title">Involvement of p38 MAPK in Synaptic
Function and Dysfunction</span>. <span class="ref-journal">Int. J. Mol. Sci.</span>
2020, <span class="ref-vol">21</span>, 5624. 10.3390/ijms21165624. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7460549/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32781522" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fijms21165624" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Involvement+of+p38+MAPK+in+Synaptic&#10;Function+and+Dysfunction&amp;author=C.+Falcicchia&amp;author=F.+Tozzi&amp;author=O.+Arancio&amp;author=D.+M.+Watterson&amp;author=N.+Origlia&amp;volume=21&amp;publication_year=2020&amp;pages=5624&amp;pmid=32781522&amp;doi=10.3390/ijms21165624&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref5"><span class="mixed-citation" id="cit5">Raghavendra N. M.; Pingili D.; Kadasi S.; Mettu A.; Prasad S. V. U. M.
<span class="ref-title">Dual
or multi-targeting inhibitors: The next generation anticancer agents</span>. <span class="ref-journal">Eur. J. Med. Chem.</span>
2018, <span class="ref-vol">143</span>, 1277&#x02013;1300. 10.1016/j.ejmech.2017.10.021. [<a href="https://pubmed.ncbi.nlm.nih.gov/29126724" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ejmech.2017.10.021" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Med.+Chem.&amp;title=Dual&#10;or+multi-targeting+inhibitors:+The+next+generation+anticancer+agents&amp;author=N.+M.+Raghavendra&amp;author=D.+Pingili&amp;author=S.+Kadasi&amp;author=A.+Mettu&amp;author=S.+V.+U.+M.+Prasad&amp;volume=143&amp;publication_year=2018&amp;pages=1277-1300&amp;pmid=29126724&amp;doi=10.1016/j.ejmech.2017.10.021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref6"><span class="mixed-citation" id="cit6">Grimes J. M.; Grimes K. V.
<span class="ref-title">p38 MAPK inhibition: A promising therapeutic approach
for COVID-19</span>. <span class="ref-journal">J. Mol. Cell. Cardiol.</span>
2020, <span class="ref-vol">144</span>, 63&#x02013;65. 10.1016/j.yjmcc.2020.05.007. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7228886/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32422320" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.yjmcc.2020.05.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Mol.+Cell.+Cardiol.&amp;title=p38+MAPK+inhibition:+A+promising+therapeutic+approach&#10;for+COVID-19&amp;author=J.+M.+Grimes&amp;author=K.+V.+Grimes&amp;volume=144&amp;publication_year=2020&amp;pages=63-65&amp;pmid=32422320&amp;doi=10.1016/j.yjmcc.2020.05.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref7"><span class="mixed-citation" id="cit7">Yeung Y. T.; Aziz F.; Guerrero-Castilla A.; Arguelles S.
<span class="ref-title">Signaling
Pathways in Inflammation and Anti-inflammatory Therapies</span>. <span class="ref-journal">Curr. Pharm. Des.</span>
2018, <span class="ref-vol">24</span>, 1449&#x02013;1484. 10.2174/1381612824666180327165604. [<a href="https://pubmed.ncbi.nlm.nih.gov/29589535" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2174%2F1381612824666180327165604" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Pharm.+Des.&amp;title=Signaling&#10;Pathways+in+Inflammation+and+Anti-inflammatory+Therapies&amp;author=Y.+T.+Yeung&amp;author=F.+Aziz&amp;author=A.+Guerrero-Castilla&amp;author=S.+Arguelles&amp;volume=24&amp;publication_year=2018&amp;pages=1449-1484&amp;pmid=29589535&amp;doi=10.2174/1381612824666180327165604&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref8"><span class="mixed-citation" id="cit8">Chen L.; Deng H.; Cui H.; Fang J.; Zuo Z.; Deng J.; Li Y.; Wang X.; Zhao L.
<span class="ref-title">Inflammatory
responses and inflammation-associated diseases in organs</span>. <span class="ref-journal">Oncotarget</span>
2017, <span class="ref-vol">9</span>, 7204&#x02013;7218. 10.18632/oncotarget.23208. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5805548/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29467962" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.23208" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Inflammatory&#10;responses+and+inflammation-associated+diseases+in+organs&amp;author=L.+Chen&amp;author=H.+Deng&amp;author=H.+Cui&amp;author=J.+Fang&amp;author=Z.+Zuo&amp;volume=9&amp;publication_year=2017&amp;pages=7204-7218&amp;pmid=29467962&amp;doi=10.18632/oncotarget.23208&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref9"><span class="mixed-citation" id="cit9">Cuadrado A.; Nebreda A. R.
<span class="ref-title">Mechanisms and functions
of p38 MAPK signalling</span>. <span class="ref-journal">Biochem. J.</span>
2010, <span class="ref-vol">429</span>, 403&#x02013;417. 10.1042/bj20100323. [<a href="https://pubmed.ncbi.nlm.nih.gov/20626350" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1042%2Fbj20100323" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+J.&amp;title=Mechanisms+and+functions&#10;of+p38+MAPK+signalling&amp;author=A.+Cuadrado&amp;author=A.+R.+Nebreda&amp;volume=429&amp;publication_year=2010&amp;pages=403-417&amp;pmid=20626350&amp;doi=10.1042/bj20100323&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref10"><span class="mixed-citation" id="cit10">Sabio G.; Davis R. J.
<span class="ref-title">TNF and MAP kinase signalling pathways</span>. <span class="ref-journal">Semin. Immunol.</span>
2014, <span class="ref-vol">26</span>, 237&#x02013;245. 10.1016/j.smim.2014.02.009. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4099309/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24647229" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.smim.2014.02.009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin.+Immunol.&amp;title=TNF+and+MAP+kinase+signalling+pathways&amp;author=G.+Sabio&amp;author=R.+J.+Davis&amp;volume=26&amp;publication_year=2014&amp;pages=237-245&amp;pmid=24647229&amp;doi=10.1016/j.smim.2014.02.009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref11"><span class="mixed-citation" id="cit11">Yang C.; Cao P.; Gao Y.; Wu M.; Lin Y.; Tian Y.; Yuan W.
<span class="ref-title">Differential expression
of p38 MAPK &#x003b1;, &#x003b2;, &#x003b3;, &#x003b4;
isoforms in nucleus pulposus modulates macrophage polarization in
intervertebral disc degeneration</span>. <span class="ref-journal">Sci. Rep.</span>
2016, <span class="ref-vol">6</span>, 22182. 10.1038/srep22182. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4766431/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26911458" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsrep22182" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=Differential+expression&#10;of+p38+MAPK+&#x003b1;,+&#x003b2;,+&#x003b3;,+&#x003b4;&#10;isoforms+in+nucleus+pulposus+modulates+macrophage+polarization+in&#10;intervertebral+disc+degeneration&amp;author=C.+Yang&amp;author=P.+Cao&amp;author=Y.+Gao&amp;author=M.+Wu&amp;author=Y.+Lin&amp;volume=6&amp;publication_year=2016&amp;pages=22182&amp;pmid=26911458&amp;doi=10.1038/srep22182&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref12"><span class="mixed-citation" id="cit12">Awasthi A.; Raju M. B.; Rahman M. A.
<span class="ref-title">Current Insights of Inhibitors of
p38 Mitogen-Activated Protein Kinase in Inflammation</span>. <span class="ref-journal">Med. Chem.</span>
2021, <span class="ref-vol">17</span>, 555&#x02013;575. 10.2174/18756638mta0codg72. [<a href="https://pubmed.ncbi.nlm.nih.gov/32106802" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2174%2F18756638mta0codg72" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med.+Chem.&amp;title=Current+Insights+of+Inhibitors+of&#10;p38+Mitogen-Activated+Protein+Kinase+in+Inflammation&amp;author=A.+Awasthi&amp;author=M.+B.+Raju&amp;author=M.+A.+Rahman&amp;volume=17&amp;publication_year=2021&amp;pages=555-575&amp;pmid=32106802&amp;doi=10.2174/18756638mta0codg72&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref13"><span class="mixed-citation" id="cit13">Kong T. T.; Zhang C. M.; Liu Z. P.
<span class="ref-title">Recent
Developments of p38&#x00026;amp;alpha;
MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole
Scaffolds</span>. <span class="ref-journal">Curr. Med. Chem.</span>
2013, <span class="ref-vol">20</span>, 1997&#x02013;2016. 10.2174/0929867311320150006. [<a href="https://pubmed.ncbi.nlm.nih.gov/23317165" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2174%2F0929867311320150006" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Med.+Chem.&amp;title=Recent&#10;Developments+of+p38&#x00026;amp;alpha;&#10;MAP+Kinase+Inhibitors+as+Antiinflammatory+Agents+Based+on+the+Imidazole&#10;Scaffolds&amp;author=T.+T.+Kong&amp;author=C.+M.+Zhang&amp;author=Z.+P.+Liu&amp;volume=20&amp;publication_year=2013&amp;pages=1997-2016&amp;pmid=23317165&amp;doi=10.2174/0929867311320150006&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref14"><span class="mixed-citation" id="cit14">Kulkarni R. G.; Laufer S. A.; Chandrashekar V. M.; Garlapati A.
<span class="ref-title">Synthesis,
p38 kinase inhibitory and anti-inflammatory activity of new substituted
benzimidazole derivatives</span>. <span class="ref-journal">Med. Chem.</span>
2013, <span class="ref-vol">9</span>, 91&#x02013;99. 10.2174/157340613804488440. [<a href="https://pubmed.ncbi.nlm.nih.gov/22946527" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2174%2F157340613804488440" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med.+Chem.&amp;title=Synthesis,&#10;p38+kinase+inhibitory+and+anti-inflammatory+activity+of+new+substituted&#10;benzimidazole+derivatives&amp;author=R.+G.+Kulkarni&amp;author=S.+A.+Laufer&amp;author=V.+M.+Chandrashekar&amp;author=A.+Garlapati&amp;volume=9&amp;publication_year=2013&amp;pages=91-99&amp;pmid=22946527&amp;doi=10.2174/157340613804488440&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref15"><span class="mixed-citation" id="cit15">Dunetz J. R.; Magano J.; Weisenburger G. A.; Gerald A. W.
<span class="ref-title">Large-Scale Applications
of Amide Coupling Reagents for the Synthesis of Pharmaceuticals</span>. <span class="ref-journal">Org. Process Res. Dev.</span>
2016, <span class="ref-vol">20</span>, 140&#x02013;177. 10.1021/op500305s. [<a href="//doi.org/10.1021%2Fop500305s" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Org.+Process+Res.+Dev.&amp;title=Large-Scale+Applications&#10;of+Amide+Coupling+Reagents+for+the+Synthesis+of+Pharmaceuticals&amp;author=J.+R.+Dunetz&amp;author=J.+Magano&amp;author=G.+A.+Weisenburger&amp;author=A.+W.+Gerald&amp;volume=20&amp;publication_year=2016&amp;pages=140-177&amp;doi=10.1021/op500305s&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref16"><span class="mixed-citation" id="cit16">Sabatini M. T.; Boulton L. T.; Sneddon H. F.; Sheppard T. D.
<span class="ref-title">A green chemistry
perspective on catalytic amide bond formation</span>. <span class="ref-journal">Nat. Catal.</span>
2019, <span class="ref-vol">2</span>, 10&#x02013;17. 10.1038/s41929-018-0211-5. [<a href="//doi.org/10.1038%2Fs41929-018-0211-5" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Catal.&amp;title=A+green+chemistry&#10;perspective+on+catalytic+amide+bond+formation&amp;author=M.+T.+Sabatini&amp;author=L.+T.+Boulton&amp;author=H.+F.+Sneddon&amp;author=T.+D.+Sheppard&amp;volume=2&amp;publication_year=2019&amp;pages=10-17&amp;doi=10.1038/s41929-018-0211-5&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref17"><span class="mixed-citation" id="cit17">Wilson K. L.; Murray J.; Jamieson C.; Watson A. J. B.
<span class="ref-title">Cyrene as a bio-based
solvent for HATU mediated amide coupling</span>. <span class="ref-journal">Org.
Biomol. Chem.</span>
2018, <span class="ref-vol">16</span>, 2851&#x02013;2854. 10.1039/c8ob00653a. [<a href="https://pubmed.ncbi.nlm.nih.gov/29630081" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1039%2Fc8ob00653a" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Org.&#10;Biomol.+Chem.&amp;title=Cyrene+as+a+bio-based&#10;solvent+for+HATU+mediated+amide+coupling&amp;author=K.+L.+Wilson&amp;author=J.+Murray&amp;author=C.+Jamieson&amp;author=A.+J.+B.+Watson&amp;volume=16&amp;publication_year=2018&amp;pages=2851-2854&amp;pmid=29630081&amp;doi=10.1039/c8ob00653a&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref18"><span class="mixed-citation" id="cit18">Wang L.; Casey M. C.; Vernekar S. K. V.; Sahani R. L.; Kankanala J.; Kirby K. A.; Du H.; Hachiya A.; Zhang H.; Tedbury P. R.; Xie J.; Sarafianos S. G.; Wang Z.
<span class="ref-title">Novel HIV-1 capsid-targeting small
molecules of the PF74 binding
site</span>. <span class="ref-journal">Eur. J. Med. Chem.</span>
2020, <span class="ref-vol">204</span>, 112626. 10.1016/j.ejmech.2020.112626. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7530112/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32814250" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ejmech.2020.112626" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Med.+Chem.&amp;title=Novel+HIV-1+capsid-targeting+small&#10;molecules+of+the+PF74+binding&#10;site&amp;author=L.+Wang&amp;author=M.+C.+Casey&amp;author=S.+K.+V.+Vernekar&amp;author=R.+L.+Sahani&amp;author=J.+Kankanala&amp;volume=204&amp;publication_year=2020&amp;pages=112626&amp;pmid=32814250&amp;doi=10.1016/j.ejmech.2020.112626&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref19"><span class="mixed-citation" id="cit19">Williams L. A. D.; O&#x02019;connar A.; Latore L.; Dennis O.; Ringer S.; Whittaker J. A.; Conrad J.; Vogler B.; Rosner H.; Kraus W.
<span class="ref-title">The in vitro anti-denaturation effects
induced by natural products and non-steroidal compounds in heat-treated
(immunogenic) bovine serum albumin is proposed as a screening assay
for the detection of anti-inflammatory compounds, without the use
of animals, in the early stages of the drug discovery process</span>. <span class="ref-journal">West Indian Med. J.</span>
2008, <span class="ref-vol">57</span>, 327. [<a href="https://pubmed.ncbi.nlm.nih.gov/19566010" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=West+Indian+Med.+J.&amp;title=The+in+vitro+anti-denaturation+effects&#10;induced+by+natural+products+and+non-steroidal+compounds+in+heat-treated&#10;(immunogenic)+bovine+serum+albumin+is+proposed+as+a+screening+assay&#10;for+the+detection+of+anti-inflammatory+compounds,+without+the+use&#10;of+animals,+in+the+early+stages+of+the+drug+discovery+process&amp;author=L.+A.+D.+Williams&amp;author=A.+O&#x02019;connar&amp;author=L.+Latore&amp;author=O.+Dennis&amp;author=S.+Ringer&amp;volume=57&amp;publication_year=2008&amp;pages=327&amp;pmid=19566010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref20"><span class="mixed-citation" id="cit20">Dhanik A.; McMurray J. S.; Kavraki L. E.
<span class="ref-title">DINC: A
new AutoDock-based protocol
for docking large ligands</span>. <span class="ref-journal">BMC Struct. Biol.</span>
2013, <span class="ref-vol">13</span>, S11. 10.1186/1472-6807-13-s1-s11. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3952135/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24564952" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F1472-6807-13-s1-s11" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Struct.+Biol.&amp;title=DINC:+A&#10;new+AutoDock-based+protocol&#10;for+docking+large+ligands&amp;author=A.+Dhanik&amp;author=J.+S.+McMurray&amp;author=L.+E.+Kavraki&amp;volume=13&amp;publication_year=2013&amp;pages=S11&amp;pmid=24564952&amp;doi=10.1186/1472-6807-13-s1-s11&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="ref21"><span class="mixed-citation" id="cit21">Daina A.; Michielin O.; Zoete V.
<span class="ref-title">SwissADME: a free web
tool to evaluate
pharmacokinetics, drug-likeness and medicinal chemistry friendliness
of small molecules</span>. <span class="ref-journal">Sci. Rep.</span>
2017, <span class="ref-vol">7</span>, 42717. 10.1038/srep42717. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5335600/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28256516" ref="reftype=pubmed&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsrep42717" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=SwissADME:+a+free+web&#10;tool+to+evaluate&#10;pharmacokinetics,+drug-likeness+and+medicinal+chemistry+friendliness&#10;of+small+molecules&amp;author=A.+Daina&amp;author=O.+Michielin&amp;author=V.+Zoete&amp;volume=7&amp;publication_year=2017&amp;pages=42717&amp;pmid=28256516&amp;doi=10.1038/srep42717&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10210024&amp;issue-id=436550&amp;journal-id=3686&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">ACS Omega</span> are provided here courtesy of <strong>American Chemical Society</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10210024/pdf/ao3c00605.pdf" class="int-view">PDF (4.3M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10210024/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10210024/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10210024" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10210024%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="1CLgcmIFptsTIqxRlbKRx0CHyjvXL4LDcCvo57wZLHyvUxFRJayHOCz1MaIGfkRo">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10210024%2F&amp;text=Synthesis%2C%20In%20Silico%0AStudies%2C%20and%20In%20Vitro%20Anti-Inflammatory%0AActivity%20of%20Novel%20Imidazole%20Derivatives%20Targeting%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10210024%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210024/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10210024/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37251188/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10210024/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37251188/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10210024/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10210024/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10210024/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
